| GO Terms | Score | Description |
|---|---|---|
| GO:0008150 | 99.04% | biological_process |
| GO:0065007 | 98.40% | biological regulation |
| GO:0050789 | 98.15% | regulation of biological process |
| GO:0050794 | 97.06% | regulation of cellular process |
| GO:0031323 | 96.23% | regulation of cellular metabolic process |
| GO:0080090 | 95.89% | regulation of primary metabolic process |
| GO:0019222 | 95.58% | regulation of metabolic process |
| GO:0051171 | 95.36% | regulation of nitrogen compound metabolic process |
| GO:0051246 | 95.12% | regulation of protein metabolic process |
| GO:0060255 | 94.81% | regulation of macromolecule metabolic process |
| GO:0032268 | 94.59% | regulation of cellular protein metabolic process |
| GO:0065009 | 92.39% | regulation of molecular function |
| GO:0051247 | 91.76% | positive regulation of protein metabolic process |
| GO:0031399 | 91.73% | regulation of protein modification process |
| GO:0009987 | 91.71% | cellular process |
| GO:0032270 | 90.87% | positive regulation of cellular protein metabolic process |
| GO:0050790 | 90.85% | regulation of catalytic activity |
| GO:0051174 | 90.62% | regulation of phosphorus metabolic process |
| GO:0019220 | 90.32% | regulation of phosphate metabolic process |
| GO:0043269 | 89.66% | regulation of ion transport |
| GO:0071280 | 89.58% | cellular response to copper ion |
| GO:0031325 | 89.49% | positive regulation of cellular metabolic process |
| GO:0043525 | 89.40% | positive regulation of neuron apoptotic process |
| GO:0051173 | 89.24% | positive regulation of nitrogen compound metabolic process |
| GO:1901216 | 89.08% | positive regulation of neuron death |
| GO:1903959 | 88.98% | regulation of anion transmembrane transport |
| GO:0048518 | 88.86% | positive regulation of biological process |
| GO:0031401 | 88.81% | positive regulation of protein modification process |
| GO:0016043 | 88.71% | cellular component organization |
| GO:0048522 | 88.68% | positive regulation of cellular process |
| GO:0001932 | 88.60% | regulation of protein phosphorylation |
| GO:0042325 | 88.11% | regulation of phosphorylation |
| GO:0071840 | 88.06% | cellular component organization or biogenesis |
| GO:0010604 | 87.98% | positive regulation of macromolecule metabolic process |
| GO:0046688 | 87.96% | response to copper ion |
| GO:0009893 | 87.82% | positive regulation of metabolic process |
| GO:0044093 | 87.61% | positive regulation of molecular function |
| GO:0010562 | 87.51% | positive regulation of phosphorus metabolic process |
| GO:0031648 | 87.47% | protein destabilization |
| GO:0045937 | 87.19% | positive regulation of phosphate metabolic process |
| GO:0051049 | 87.14% | regulation of transport |
| GO:0043085 | 87.06% | positive regulation of catalytic activity |
| GO:0050896 | 86.75% | response to stimulus |
| GO:1904646 | 86.22% | cellular response to amyloid-beta |
| GO:0045859 | 86.00% | regulation of protein kinase activity |
| GO:0034765 | 85.75% | regulation of ion transmembrane transport |
| GO:0019722 | 85.56% | calcium-mediated signaling |
| GO:0032879 | 85.48% | regulation of localization |
| GO:0043549 | 85.13% | regulation of kinase activity |
| GO:1901653 | 84.86% | cellular response to peptide |
| GO:0042327 | 84.84% | positive regulation of phosphorylation |
| GO:0044070 | 84.45% | regulation of anion transport |
| GO:0051338 | 84.39% | regulation of transferase activity |
| GO:0065008 | 84.29% | regulation of biological quality |
| GO:0035556 | 84.27% | intracellular signal transduction |
| GO:0061098 | 84.25% | positive regulation of protein tyrosine kinase activity |
| GO:0032409 | 84.17% | regulation of transporter activity |
| GO:1904645 | 84.07% | response to amyloid-beta |
| GO:0010941 | 84.06% | regulation of cell death |
| GO:0034762 | 83.60% | regulation of transmembrane transport |
| GO:0022898 | 83.49% | regulation of transmembrane transporter activity |
| GO:0051259 | 83.41% | protein complex oligomerization |
| GO:0043067 | 83.27% | regulation of programmed cell death |
| GO:0061097 | 83.22% | regulation of protein tyrosine kinase activity |
| GO:0033674 | 83.18% | positive regulation of kinase activity |
| GO:0071417 | 83.00% | cellular response to organonitrogen compound |
| GO:0010038 | 82.90% | response to metal ion |
| GO:0043523 | 82.88% | regulation of neuron apoptotic process |
| GO:0042981 | 82.87% | regulation of apoptotic process |
| GO:0051260 | 82.80% | protein homooligomerization |
| GO:0051347 | 82.79% | positive regulation of transferase activity |
| GO:0032412 | 82.74% | regulation of ion transmembrane transporter activity |
| GO:0042221 | 82.67% | response to chemical |
| GO:1901214 | 82.66% | regulation of neuron death |
| GO:0001934 | 82.57% | positive regulation of protein phosphorylation |
| GO:0045860 | 82.50% | positive regulation of protein kinase activity |
| GO:0051716 | 82.18% | cellular response to stimulus |
| GO:0007165 | 81.85% | signal transduction |
| GO:0071495 | 81.76% | cellular response to endogenous stimulus |
| GO:0043933 | 81.17% | protein-containing complex subunit organization |
| GO:0070887 | 81.03% | cellular response to chemical stimulus |
| GO:0019932 | 80.34% | second-messenger-mediated signaling |
| GO:0071248 | 80.29% | cellular response to metal ion |
| GO:0043065 | 80.04% | positive regulation of apoptotic process |
| GO:0010035 | 79.97% | response to inorganic substance |
| GO:0010942 | 79.94% | positive regulation of cell death |
| GO:0071310 | 79.88% | cellular response to organic substance |
| GO:1901700 | 79.76% | response to oxygen-containing compound |
| GO:1901699 | 79.34% | cellular response to nitrogen compound |
| GO:0010033 | 79.08% | response to organic substance |
| GO:0009719 | 78.89% | response to endogenous stimulus |
| GO:0043068 | 78.69% | positive regulation of programmed cell death |
| GO:0031647 | 78.55% | regulation of protein stability |
| GO:0010243 | 78.49% | response to organonitrogen compound |
| GO:0071241 | 78.31% | cellular response to inorganic substance |
| GO:1901698 | 78.17% | response to nitrogen compound |
| GO:1901701 | 77.78% | cellular response to oxygen-containing compound |
| GO:1901652 | 77.69% | response to peptide |
| GO:0065003 | 77.50% | protein-containing complex assembly |
| GO:0022607 | 76.53% | cellular component assembly |
| GO:0042130 | 76.40% | negative regulation of T cell proliferation |
| GO:0010522 | 75.81% | regulation of calcium ion transport into cytosol |
| GO:0050868 | 75.31% | negative regulation of T cell activation |
| GO:0050858 | 75.05% | negative regulation of antigen receptor-mediated signaling pathway |
| GO:0048583 | 74.98% | regulation of response to stimulus |
| GO:0070884 | 74.88% | regulation of calcineurin-NFAT signaling cascade |
| GO:0050672 | 74.65% | negative regulation of lymphocyte proliferation |
| GO:0032945 | 74.34% | negative regulation of mononuclear cell proliferation |
| GO:0051250 | 74.32% | negative regulation of lymphocyte activation |
| GO:0048519 | 74.25% | negative regulation of biological process |
| GO:1903038 | 74.20% | negative regulation of leukocyte cell-cell adhesion |
| GO:0090314 | 74.16% | positive regulation of protein targeting to membrane |
| GO:0070664 | 74.14% | negative regulation of leukocyte proliferation |
| GO:0009966 | 74.12% | regulation of signal transduction |
| GO:0046006 | 74.03% | regulation of activated T cell proliferation |
| GO:0023051 | 74.01% | regulation of signaling |
| GO:0010959 | 74.01% | regulation of metal ion transport |
| GO:0106056 | 73.99% | regulation of calcineurin-mediated signaling |
| GO:0050849 | 73.81% | negative regulation of calcium-mediated signaling |
| GO:0010646 | 73.66% | regulation of cell communication |
| GO:0022408 | 73.54% | negative regulation of cell-cell adhesion |
| GO:1904377 | 73.34% | positive regulation of protein localization to cell periphery |
| GO:0090313 | 73.22% | regulation of protein targeting to membrane |
| GO:0051924 | 73.20% | regulation of calcium ion transport |
| GO:0050866 | 73.17% | negative regulation of cell activation |
| GO:1902531 | 72.82% | regulation of intracellular signal transduction |
| GO:0050856 | 72.75% | regulation of T cell receptor signaling pathway |
| GO:0050730 | 72.71% | regulation of peptidyl-tyrosine phosphorylation |
| GO:0007162 | 72.62% | negative regulation of cell adhesion |
| GO:1903078 | 72.55% | positive regulation of protein localization to plasma membrane |
| GO:0002695 | 72.47% | negative regulation of leukocyte activation |
| GO:0042129 | 72.41% | regulation of T cell proliferation |
| GO:0032660 | 72.05% | regulation of interleukin-17 production |
| GO:0048523 | 71.85% | negative regulation of cellular process |
| GO:1902003 | 71.85% | regulation of amyloid-beta formation |
| GO:1905477 | 71.79% | positive regulation of protein localization to membrane |
| GO:0050854 | 71.60% | regulation of antigen receptor-mediated signaling pathway |
| GO:0032944 | 71.38% | regulation of mononuclear cell proliferation |
| GO:0050670 | 71.06% | regulation of lymphocyte proliferation |
| GO:0060341 | 70.92% | regulation of cellular localization |
| GO:1903076 | 70.86% | regulation of protein localization to plasma membrane |
| GO:0050731 | 70.77% | positive regulation of peptidyl-tyrosine phosphorylation |
| GO:0070663 | 70.75% | regulation of leukocyte proliferation |
| GO:1903037 | 70.57% | regulation of leukocyte cell-cell adhesion |
| GO:2001141 | 70.56% | regulation of RNA biosynthetic process |
| GO:0006355 | 70.33% | regulation of transcription, DNA-templated |
| GO:1901379 | 70.17% | regulation of potassium ion transmembrane transport |
| GO:0090279 | 70.13% | regulation of calcium ion import |
| GO:0002694 | 70.08% | regulation of leukocyte activation |
| GO:1904375 | 70.07% | regulation of protein localization to cell periphery |
| GO:0050865 | 70.04% | regulation of cell activation |
| GO:0050863 | 69.88% | regulation of T cell activation |
| GO:1904062 | 69.81% | regulation of cation transmembrane transport |
| GO:0043266 | 69.64% | regulation of potassium ion transport |
| GO:1903169 | 69.63% | regulation of calcium ion transmembrane transport |
| GO:1903506 | 69.56% | regulation of nucleic acid-templated transcription |
| GO:0022407 | 69.54% | regulation of cell-cell adhesion |
| GO:1905809 | 69.40% | negative regulation of synapse organization |
| GO:0031324 | 69.25% | negative regulation of cellular metabolic process |
| GO:1900449 | 69.14% | regulation of glutamate receptor signaling pathway |
| GO:0046686 | 69.10% | response to cadmium ion |
| GO:1900271 | 69.04% | regulation of long-term synaptic potentiation |
| GO:0032663 | 68.82% | regulation of interleukin-2 production |
| GO:0051249 | 68.80% | regulation of lymphocyte activation |
| GO:0032689 | 68.79% | negative regulation of interferon-gamma production |
| GO:1902991 | 68.73% | regulation of amyloid precursor protein catabolic process |
| GO:0106027 | 68.55% | neuron projection organization |
| GO:0051172 | 68.42% | negative regulation of nitrogen compound metabolic process |
| GO:1903533 | 68.41% | regulation of protein targeting |
| GO:0009892 | 68.41% | negative regulation of metabolic process |
| GO:0009889 | 68.08% | regulation of biosynthetic process |
| GO:0051252 | 68.01% | regulation of RNA metabolic process |
| GO:0019219 | 67.99% | regulation of nucleobase-containing compound metabolic process |
| GO:0032147 | 67.90% | activation of protein kinase activity |
| GO:0032269 | 67.81% | negative regulation of cellular protein metabolic process |
| GO:0050848 | 67.76% | regulation of calcium-mediated signaling |
| GO:2000112 | 67.72% | regulation of cellular macromolecule biosynthetic process |
| GO:0044092 | 67.63% | negative regulation of molecular function |
| GO:0010556 | 67.40% | regulation of macromolecule biosynthetic process |
| GO:1905475 | 67.36% | regulation of protein localization to membrane |
| GO:0010605 | 67.29% | negative regulation of macromolecule metabolic process |
| GO:0051050 | 67.15% | positive regulation of transport |
| GO:0031326 | 66.97% | regulation of cellular biosynthetic process |
| GO:0051248 | 66.85% | negative regulation of protein metabolic process |
| GO:0051239 | 66.53% | regulation of multicellular organismal process |
| GO:0031400 | 66.47% | negative regulation of protein modification process |
| GO:0048585 | 66.27% | negative regulation of response to stimulus |
| GO:0032649 | 66.23% | regulation of interferon-gamma production |
| GO:0002683 | 66.13% | negative regulation of immune system process |
| GO:0009968 | 66.08% | negative regulation of signal transduction |
| GO:0099175 | 66.02% | regulation of postsynapse organization |
| GO:0030155 | 65.78% | regulation of cell adhesion |
| GO:1904951 | 65.64% | positive regulation of establishment of protein localization |
| GO:1902532 | 65.58% | negative regulation of intracellular signal transduction |
| GO:0034249 | 65.51% | negative regulation of cellular amide metabolic process |
| GO:0032880 | 65.51% | regulation of protein localization |
| GO:0043433 | 65.28% | negative regulation of DNA-binding transcription factor activity |
| GO:0010468 | 64.87% | regulation of gene expression |
| GO:0051090 | 64.46% | regulation of DNA-binding transcription factor activity |
| GO:0051222 | 64.45% | positive regulation of protein transport |
| GO:1903827 | 64.34% | regulation of cellular protein localization |
| GO:0001933 | 64.34% | negative regulation of protein phosphorylation |
| GO:0008285 | 64.05% | negative regulation of cell population proliferation |
| GO:0010648 | 64.04% | negative regulation of cell communication |
| GO:0006950 | 64.04% | response to stress |
| GO:0023057 | 64.02% | negative regulation of signaling |
| GO:1903829 | 63.69% | positive regulation of cellular protein localization |
| GO:0051128 | 63.63% | regulation of cellular component organization |
| GO:0045936 | 63.53% | negative regulation of phosphate metabolic process |
| GO:0048167 | 63.21% | regulation of synaptic plasticity |
| GO:0010563 | 62.89% | negative regulation of phosphorus metabolic process |
| GO:0002682 | 62.88% | regulation of immune system process |
| GO:0032501 | 62.66% | multicellular organismal process |
| GO:0051129 | 62.64% | negative regulation of cellular component organization |
| GO:0009410 | 61.77% | response to xenobiotic stimulus |
| GO:0042326 | 61.76% | negative regulation of phosphorylation |
| GO:0042127 | 61.63% | regulation of cell population proliferation |
| GO:0032388 | 61.62% | positive regulation of intracellular transport |
| GO:0003008 | 61.48% | system process |
| GO:0050807 | 61.16% | regulation of synapse organization |
| GO:0001818 | 61.12% | negative regulation of cytokine production |
| GO:0050890 | 61.04% | cognition |
| GO:0050877 | 60.86% | nervous system process |
| GO:0051241 | 60.64% | negative regulation of multicellular organismal process |
| GO:0090316 | 60.61% | positive regulation of intracellular protein transport |
| GO:0006979 | 60.41% | response to oxidative stress |
| GO:0032386 | 60.41% | regulation of intracellular transport |
| GO:0007611 | 60.29% | learning or memory |
| GO:0060548 | 60.05% | negative regulation of cell death |
| GO:0050776 | 59.97% | regulation of immune response |
| GO:0070201 | 59.96% | regulation of establishment of protein localization |
| GO:0043069 | 59.91% | negative regulation of programmed cell death |
| GO:0043066 | 59.67% | negative regulation of apoptotic process |
| GO:0090087 | 59.32% | regulation of peptide transport |
| GO:0034248 | 58.92% | regulation of cellular amide metabolic process |
| GO:0051223 | 58.85% | regulation of protein transport |
| GO:0033157 | 58.53% | regulation of intracellular protein transport |
| GO:0031345 | 58.53% | negative regulation of cell projection organization |
| GO:0050804 | 58.29% | modulation of chemical synaptic transmission |
| GO:0099177 | 58.01% | regulation of trans-synaptic signaling |
| GO:0071466 | 57.30% | cellular response to xenobiotic stimulus |
| GO:0120035 | 56.97% | regulation of plasma membrane bounded cell projection organization |
| GO:0031344 | 56.60% | regulation of cell projection organization |
| GO:0007610 | 56.03% | behavior |
| GO:0001817 | 55.48% | regulation of cytokine production |
| GO:0120036 | 55.18% | plasma membrane bounded cell projection organization |
| GO:0048878 | 54.60% | chemical homeostasis |
| GO:0042592 | 54.16% | homeostatic process |
| GO:0006875 | 53.06% | cellular metal ion homeostasis |
| GO:0030030 | 52.97% | cell projection organization |
| GO:0050801 | 52.32% | ion homeostasis |
| GO:0055082 | 51.89% | cellular chemical homeostasis |
| GO:0006873 | 51.86% | cellular ion homeostasis |
| GO:0030003 | 51.85% | cellular cation homeostasis |
| GO:0019725 | 51.30% | cellular homeostasis |
| GO:0055065 | 51.06% | metal ion homeostasis |
| GO:0098771 | 50.74% | inorganic ion homeostasis |
| GO:0046916 | 50.12% | cellular transition metal ion homeostasis |
| GO:0055080 | 49.94% | cation homeostasis |
| GO:0006878 | 49.64% | cellular copper ion homeostasis |
| GO:0055070 | 48.67% | copper ion homeostasis |
| GO:0055076 | 44.59% | transition metal ion homeostasis |
| GO:0043086 | 43.67% | negative regulation of catalytic activity |
| GO:0010629 | 29.92% | negative regulation of gene expression |
| GO:0007049 | 29.50% | cell cycle |
| GO:0099173 | 28.02% | postsynapse organization |
| GO:1903318 | 27.90% | negative regulation of protein maturation |
| GO:0010955 | 27.81% | negative regulation of protein processing |
| GO:0030162 | 27.65% | regulation of proteolysis |
| GO:0070613 | 27.51% | regulation of protein processing |
| GO:0007616 | 27.43% | long-term memory |
| GO:1903317 | 27.33% | regulation of protein maturation |
| GO:0097061 | 27.04% | dendritic spine organization |
| GO:0043954 | 25.59% | cellular component maintenance |
| GO:0007613 | 24.07% | memory |
| GO:0008152 | 24.03% | metabolic process |
| GO:0045861 | 23.85% | negative regulation of proteolysis |
| GO:0044237 | 21.93% | cellular metabolic process |
| GO:0071704 | 21.11% | organic substance metabolic process |
| GO:0006807 | 20.73% | nitrogen compound metabolic process |
| GO:0044238 | 19.31% | primary metabolic process |
| GO:0023056 | 18.99% | positive regulation of signaling |
| GO:0010647 | 18.92% | positive regulation of cell communication |
| GO:0048584 | 18.06% | positive regulation of response to stimulus |
| GO:0034641 | 17.98% | cellular nitrogen compound metabolic process |
| GO:0006139 | 17.90% | nucleobase-containing compound metabolic process |
| GO:1901360 | 17.82% | organic cyclic compound metabolic process |
| GO:1902533 | 17.66% | positive regulation of intracellular signal transduction |
| GO:0006725 | 17.52% | cellular aromatic compound metabolic process |
| GO:0043270 | 17.50% | positive regulation of ion transport |
| GO:0046483 | 17.37% | heterocycle metabolic process |
| GO:0009967 | 16.91% | positive regulation of signal transduction |
| GO:0051282 | 15.76% | regulation of sequestering of calcium ion |
| GO:0006996 | 15.51% | organelle organization |
| GO:0006357 | 15.31% | regulation of transcription by RNA polymerase II |
| GO:0044057 | 14.80% | regulation of system process |
| GO:0006874 | 14.53% | cellular calcium ion homeostasis |
| GO:0043408 | 14.28% | regulation of MAPK cascade |
| GO:0012501 | 14.04% | programmed cell death |
| GO:0051179 | 13.84% | localization |
| GO:0006915 | 13.77% | apoptotic process |
| GO:0090257 | 13.76% | regulation of muscle system process |
| GO:0007204 | 13.74% | positive regulation of cytosolic calcium ion concentration |
| GO:0051928 | 13.72% | positive regulation of calcium ion transport |
| GO:0051336 | 13.70% | regulation of hydrolase activity |
| GO:0097190 | 13.66% | apoptotic signaling pathway |
| GO:0055074 | 13.66% | calcium ion homeostasis |
| GO:0051345 | 13.61% | positive regulation of hydrolase activity |
| GO:0008219 | 13.51% | cell death |
| GO:0034767 | 13.43% | positive regulation of ion transmembrane transport |
| GO:0051279 | 13.43% | regulation of release of sequestered calcium ion into cytosol |
| GO:0034764 | 13.07% | positive regulation of transmembrane transport |
| GO:0061024 | 12.97% | membrane organization |
| GO:0043410 | 12.69% | positive regulation of MAPK cascade |
| GO:0048147 | 12.65% | negative regulation of fibroblast proliferation |
| GO:0072503 | 12.48% | cellular divalent inorganic cation homeostasis |
| GO:1904064 | 12.43% | positive regulation of cation transmembrane transport |
| GO:0042391 | 12.41% | regulation of membrane potential |
| GO:0050793 | 12.39% | regulation of developmental process |
| GO:0051480 | 12.09% | regulation of cytosolic calcium ion concentration |
| GO:0010524 | 12.01% | positive regulation of calcium ion transport into cytosol |
| GO:0051234 | 12.01% | establishment of localization |
| GO:0007166 | 11.96% | cell surface receptor signaling pathway |
| GO:0006937 | 11.93% | regulation of muscle contraction |
| GO:0080134 | 11.92% | regulation of response to stress |
| GO:0051051 | 11.92% | negative regulation of transport |
| GO:0014070 | 11.85% | response to organic cyclic compound |
| GO:0009628 | 11.83% | response to abiotic stimulus |
| GO:0072507 | 11.79% | divalent inorganic cation homeostasis |
| GO:0010558 | 11.67% | negative regulation of macromolecule biosynthetic process |
| GO:0032984 | 11.63% | protein-containing complex disassembly |
| GO:0032870 | 11.59% | cellular response to hormone stimulus |
| GO:2000026 | 11.54% | regulation of multicellular organismal development |
| GO:0033993 | 11.49% | response to lipid |
| GO:0045862 | 11.41% | positive regulation of proteolysis |
| GO:0045934 | 11.29% | negative regulation of nucleobase-containing compound metabolic process |
| GO:0051240 | 11.27% | positive regulation of multicellular organismal process |
| GO:0051047 | 11.14% | positive regulation of secretion |
| GO:0006810 | 11.10% | transport |
| GO:0051726 | 11.05% | regulation of cell cycle |
| GO:1902679 | 11.05% | negative regulation of RNA biosynthetic process |
| GO:0008283 | 11.02% | cell population proliferation |
| GO:0010950 | 11.01% | positive regulation of endopeptidase activity |
| GO:0048145 | 10.96% | regulation of fibroblast proliferation |
| GO:0002691 | 10.95% | regulation of cellular extravasation |
| GO:0051668 | 10.94% | localization within membrane |
| GO:2001056 | 10.94% | positive regulation of cysteine-type endopeptidase activity |
| GO:1903507 | 10.93% | negative regulation of nucleic acid-templated transcription |
| GO:0051130 | 10.93% | positive regulation of cellular component organization |
| GO:0008104 | 10.89% | protein localization |
| GO:2000113 | 10.81% | negative regulation of cellular macromolecule biosynthetic process |
| GO:0045892 | 10.79% | negative regulation of transcription, DNA-templated |
| GO:0033036 | 10.79% | macromolecule localization |
| GO:0035304 | 10.73% | regulation of protein dephosphorylation |
| GO:0032502 | 10.66% | developmental process |
| GO:0002693 | 10.62% | positive regulation of cellular extravasation |
| GO:1903532 | 10.53% | positive regulation of secretion by cell |
| GO:0009725 | 10.43% | response to hormone |
| GO:0008625 | 10.37% | extrinsic apoptotic signaling pathway via death domain receptors |
| GO:0010952 | 10.37% | positive regulation of peptidase activity |
| GO:0009890 | 10.36% | negative regulation of biosynthetic process |
| GO:0010907 | 10.34% | positive regulation of glucose metabolic process |
| GO:0033554 | 10.25% | cellular response to stress |
| GO:0051270 | 10.24% | regulation of cellular component movement |
| GO:0043113 | 10.19% | receptor clustering |
| GO:0080135 | 10.18% | regulation of cellular response to stress |
| GO:0031327 | 10.15% | negative regulation of cellular biosynthetic process |
| GO:0032233 | 10.08% | positive regulation of actin filament bundle assembly |
| GO:0034097 | 10.08% | response to cytokine |
| GO:0051281 | 10.07% | positive regulation of release of sequestered calcium ion into cytosol |
| GO:0042493 | 10.04% | response to drug |
| GO:0060627 | 10.03% | regulation of vesicle-mediated transport |
| GO:0044087 | 10.01% | regulation of cellular component biogenesis |
| GO:1904427 | 10.01% | positive regulation of calcium ion transmembrane transport |
| GO:0051649 | 9.97% | establishment of localization in cell |
| GO:0051253 | 9.96% | negative regulation of RNA metabolic process |
| GO:0045932 | 9.93% | negative regulation of muscle contraction |
| GO:0035303 | 9.90% | regulation of dephosphorylation |
| GO:0031589 | 9.85% | cell-substrate adhesion |
| GO:0009605 | 9.79% | response to external stimulus |
| GO:0051094 | 9.78% | positive regulation of developmental process |
| GO:0051592 | 9.78% | response to calcium ion |
| GO:0050869 | 9.67% | negative regulation of B cell activation |
| GO:0043122 | 9.66% | regulation of I-kappaB kinase/NF-kappaB signaling |
| GO:0035307 | 9.66% | positive regulation of protein dephosphorylation |
| GO:0071887 | 9.60% | leukocyte apoptotic process |
| GO:0007160 | 9.60% | cell-matrix adhesion |
| GO:0045786 | 9.51% | negative regulation of cell cycle |
| GO:0055117 | 9.47% | regulation of cardiac muscle contraction |
| GO:0006811 | 9.47% | ion transport |
| GO:2001233 | 9.46% | regulation of apoptotic signaling pathway |
| GO:0002376 | 9.41% | immune system process |
| GO:0035306 | 9.41% | positive regulation of dephosphorylation |
| GO:0050678 | 9.38% | regulation of epithelial cell proliferation |
| GO:0043123 | 9.37% | positive regulation of I-kappaB kinase/NF-kappaB signaling |
| GO:0007169 | 9.34% | transmembrane receptor protein tyrosine kinase signaling pathway |
| GO:0070555 | 9.33% | response to interleukin-1 |
| GO:0009636 | 9.33% | response to toxic substance |
| GO:0045822 | 9.28% | negative regulation of heart contraction |
| GO:0051046 | 9.26% | regulation of secretion |
| GO:0045597 | 9.23% | positive regulation of cell differentiation |
| GO:1901890 | 9.18% | positive regulation of cell junction assembly |
| GO:0051926 | 9.18% | negative regulation of calcium ion transport |
| GO:0042542 | 9.17% | response to hydrogen peroxide |
| GO:0031398 | 9.12% | positive regulation of protein ubiquitination |
| GO:0044089 | 9.06% | positive regulation of cellular component biogenesis |
| GO:0050806 | 9.05% | positive regulation of synaptic transmission |
| GO:0048856 | 8.93% | anatomical structure development |
| GO:0008016 | 8.93% | regulation of heart contraction |
| GO:0045595 | 8.92% | regulation of cell differentiation |
| GO:0006469 | 8.87% | negative regulation of protein kinase activity |
| GO:0033673 | 8.86% | negative regulation of kinase activity |
| GO:0031952 | 8.84% | regulation of protein autophosphorylation |
| GO:0050864 | 8.78% | regulation of B cell activation |
| GO:0031396 | 8.73% | regulation of protein ubiquitination |
| GO:0048646 | 8.72% | anatomical structure formation involved in morphogenesis |
| GO:1903793 | 8.71% | positive regulation of anion transport |
| GO:0071396 | 8.71% | cellular response to lipid |
| GO:0043547 | 8.67% | positive regulation of GTPase activity |
| GO:0051100 | 8.65% | negative regulation of binding |
| GO:0043271 | 8.63% | negative regulation of ion transport |
| GO:0048869 | 8.59% | cellular developmental process |
| GO:1903530 | 8.54% | regulation of secretion by cell |
| GO:0055081 | 8.53% | anion homeostasis |
| GO:0043280 | 8.52% | positive regulation of cysteine-type endopeptidase activity involved in apoptotic process |
| GO:0104004 | 8.49% | cellular response to environmental stimulus |
| GO:0032231 | 8.48% | regulation of actin filament bundle assembly |
| GO:0007010 | 8.47% | cytoskeleton organization |
| GO:0043409 | 8.45% | negative regulation of MAPK cascade |
| GO:0000302 | 8.42% | response to reactive oxygen species |
| GO:0032410 | 8.42% | negative regulation of transporter activity |
| GO:0007507 | 8.39% | heart development |
| GO:0043666 | 8.38% | regulation of phosphoprotein phosphatase activity |
| GO:0070372 | 8.38% | regulation of ERK1 and ERK2 cascade |
| GO:0048545 | 8.38% | response to steroid hormone |
| GO:0010676 | 8.36% | positive regulation of cellular carbohydrate metabolic process |
| GO:0097193 | 8.35% | intrinsic apoptotic signaling pathway |
| GO:0043254 | 8.35% | regulation of protein complex assembly |
| GO:0000122 | 8.35% | negative regulation of transcription by RNA polymerase II |
| GO:0030001 | 8.34% | metal ion transport |
| GO:0071214 | 8.30% | cellular response to abiotic stimulus |
| GO:0070838 | 8.26% | divalent metal ion transport |
| GO:0051348 | 8.23% | negative regulation of transferase activity |
| GO:1903322 | 8.23% | positive regulation of protein modification by small protein conjugation or removal |
| GO:0040012 | 8.22% | regulation of locomotion |
| GO:0006952 | 8.19% | defense response |
| GO:0033043 | 8.19% | regulation of organelle organization |
| GO:0007154 | 8.19% | cell communication |
| GO:0019221 | 8.19% | cytokine-mediated signaling pathway |
| GO:0031644 | 8.18% | regulation of nervous system process |
| GO:1903523 | 8.12% | negative regulation of blood circulation |
| GO:0009607 | 8.10% | response to biotic stimulus |
| GO:0034612 | 8.09% | response to tumor necrosis factor |
| GO:0098655 | 8.08% | cation transmembrane transport |
| GO:0018105 | 8.08% | peptidyl-serine phosphorylation |
| GO:0009896 | 8.08% | positive regulation of catabolic process |
| GO:0034220 | 8.07% | ion transmembrane transport |
| GO:2001235 | 8.06% | positive regulation of apoptotic signaling pathway |
| GO:0045765 | 8.05% | regulation of angiogenesis |
| GO:0010874 | 8.03% | regulation of cholesterol efflux |
| GO:0006816 | 7.99% | calcium ion transport |
| GO:1903522 | 7.98% | regulation of blood circulation |
| GO:1901983 | 7.98% | regulation of protein acetylation |
| GO:0050821 | 7.98% | protein stabilization |
| GO:0032414 | 7.97% | positive regulation of ion transmembrane transporter activity |
| GO:0006919 | 7.95% | activation of cysteine-type endopeptidase activity involved in apoptotic process |
| GO:0043087 | 7.95% | regulation of GTPase activity |
| GO:1905954 | 7.94% | positive regulation of lipid localization |
| GO:0006812 | 7.92% | cation transport |
| GO:0007167 | 7.90% | enzyme linked receptor protein signaling pathway |
| GO:0009894 | 7.90% | regulation of catabolic process |
| GO:0022610 | 7.90% | biological adhesion |
| GO:0071392 | 7.87% | cellular response to estradiol stimulus |
| GO:0031056 | 7.86% | regulation of histone modification |
| GO:0007155 | 7.85% | cell adhesion |
| GO:0072511 | 7.85% | divalent inorganic cation transport |
| GO:0009314 | 7.80% | response to radiation |
| GO:0051641 | 7.80% | cellular localization |
| GO:0010639 | 7.77% | negative regulation of organelle organization |
| GO:0022411 | 7.77% | cellular component disassembly |
| GO:0010564 | 7.76% | regulation of cell cycle process |
| GO:0010880 | 7.76% | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum |
| GO:0051898 | 7.76% | negative regulation of protein kinase B signaling |
| GO:0032411 | 7.74% | positive regulation of transporter activity |
| GO:0051091 | 7.73% | positive regulation of DNA-binding transcription factor activity |
| GO:2000145 | 7.73% | regulation of cell motility |
| GO:0052548 | 7.72% | regulation of endopeptidase activity |
| GO:0070848 | 7.71% | response to growth factor |
| GO:0086004 | 7.70% | regulation of cardiac muscle cell contraction |
| GO:2001025 | 7.68% | positive regulation of response to drug |
| GO:1903320 | 7.68% | regulation of protein modification by small protein conjugation or removal |
| GO:0048872 | 7.67% | homeostasis of number of cells |
| GO:0048513 | 7.67% | animal organ development |
| GO:0032370 | 7.67% | positive regulation of lipid transport |
| GO:0097435 | 7.66% | supramolecular fiber organization |
| GO:0035148 | 7.66% | tube formation |
| GO:0097191 | 7.66% | extrinsic apoptotic signaling pathway |
| GO:0051098 | 7.65% | regulation of binding |
| GO:1903115 | 7.62% | regulation of actin filament-based movement |
| GO:0051496 | 7.59% | positive regulation of stress fiber assembly |
| GO:0071900 | 7.59% | regulation of protein serine/threonine kinase activity |
| GO:0031329 | 7.59% | regulation of cellular catabolic process |
| GO:0090280 | 7.58% | positive regulation of calcium ion import |
| GO:0016055 | 7.57% | Wnt signaling pathway |
| GO:0010975 | 7.56% | regulation of neuron projection development |
| GO:0070232 | 7.55% | regulation of T cell apoptotic process |
| GO:0022603 | 7.51% | regulation of anatomical structure morphogenesis |
| GO:0097746 | 7.50% | regulation of blood vessel diameter |
| GO:0031058 | 7.48% | positive regulation of histone modification |
| GO:0051272 | 7.47% | positive regulation of cellular component movement |
| GO:0070849 | 7.45% | response to epidermal growth factor |
| GO:0031331 | 7.44% | positive regulation of cellular catabolic process |
| GO:1902275 | 7.43% | regulation of chromatin organization |
| GO:1902105 | 7.42% | regulation of leukocyte differentiation |
| GO:0001525 | 7.40% | angiogenesis |
| GO:0052547 | 7.39% | regulation of peptidase activity |
| GO:0032413 | 7.38% | negative regulation of ion transmembrane transporter activity |
| GO:0051894 | 7.38% | positive regulation of focal adhesion assembly |
| GO:0023052 | 7.36% | signaling |
| GO:0030002 | 7.36% | cellular anion homeostasis |
| GO:0046887 | 7.36% | positive regulation of hormone secretion |
| GO:0031334 | 7.32% | positive regulation of protein complex assembly |
| GO:0009891 | 7.31% | positive regulation of biosynthetic process |
| GO:0007517 | 7.30% | muscle organ development |
| GO:0007267 | 7.25% | cell-cell signaling |
| GO:0070374 | 7.25% | positive regulation of ERK1 and ERK2 cascade |
| GO:0032387 | 7.25% | negative regulation of intracellular transport |
| GO:1905114 | 7.24% | cell surface receptor signaling pathway involved in cell-cell signaling |
| GO:0097306 | 7.21% | cellular response to alcohol |
| GO:0034763 | 7.20% | negative regulation of transmembrane transport |
| GO:0006974 | 7.20% | cellular response to DNA damage stimulus |
| GO:0071345 | 7.18% | cellular response to cytokine stimulus |
| GO:0031638 | 7.16% | zymogen activation |
| GO:2000756 | 7.15% | regulation of peptidyl-lysine acetylation |
| GO:0008284 | 7.15% | positive regulation of cell population proliferation |
| GO:1902884 | 7.15% | positive regulation of response to oxidative stress |
| GO:0070228 | 7.11% | regulation of lymphocyte apoptotic process |
| GO:0046677 | 7.11% | response to antibiotic |
| GO:0002793 | 7.11% | positive regulation of peptide secretion |
| GO:0062012 | 7.08% | regulation of small molecule metabolic process |
| GO:0045944 | 7.07% | positive regulation of transcription by RNA polymerase II |
| GO:0002931 | 7.05% | response to ischemia |
| GO:0007568 | 7.04% | aging |
| GO:0031667 | 7.03% | response to nutrient levels |
| GO:0002684 | 7.01% | positive regulation of immune system process |
| GO:0035176 | 7.00% | social behavior |
| GO:1903828 | 7.00% | negative regulation of cellular protein localization |
| GO:1900180 | 6.99% | regulation of protein localization to nucleus |
| GO:1900117 | 6.99% | regulation of execution phase of apoptosis |
| GO:0022414 | 6.97% | reproductive process |
| GO:0043207 | 6.96% | response to external biotic stimulus |
| GO:0071356 | 6.96% | cellular response to tumor necrosis factor |
| GO:0006954 | 6.95% | inflammatory response |
| GO:0002703 | 6.94% | regulation of leukocyte mediated immunity |
| GO:0010921 | 6.93% | regulation of phosphatase activity |
| GO:2000116 | 6.92% | regulation of cysteine-type endopeptidase activity |
| GO:0010506 | 6.92% | regulation of autophagy |
| GO:0002687 | 6.90% | positive regulation of leukocyte migration |
| GO:0060249 | 6.88% | anatomical structure homeostasis |
| GO:0032970 | 6.88% | regulation of actin filament-based process |
| GO:0032088 | 6.87% | negative regulation of NF-kappaB transcription factor activity |
| GO:0022405 | 6.86% | hair cycle process |
| GO:0010212 | 6.86% | response to ionizing radiation |
| GO:0010638 | 6.86% | positive regulation of organelle organization |
| GO:0002027 | 6.85% | regulation of heart rate |
| GO:0031646 | 6.84% | positive regulation of nervous system process |
| GO:1905269 | 6.84% | positive regulation of chromatin organization |
| GO:1904994 | 6.84% | regulation of leukocyte adhesion to vascular endothelial cell |
| GO:0050765 | 6.83% | negative regulation of phagocytosis |
| GO:0010623 | 6.83% | programmed cell death involved in cell development |
| GO:0006942 | 6.82% | regulation of striated muscle contraction |
| GO:0045995 | 6.81% | regulation of embryonic development |
| GO:1901654 | 6.80% | response to ketone |
| GO:1901342 | 6.80% | regulation of vasculature development |
| GO:0060291 | 6.80% | long-term synaptic potentiation |
| GO:0043393 | 6.79% | regulation of protein binding |
| GO:1901020 | 6.79% | negative regulation of calcium ion transmembrane transporter activity |
| GO:1901564 | 6.79% | organonitrogen compound metabolic process |
| GO:0006793 | 6.78% | phosphorus metabolic process |
| GO:0030154 | 6.78% | cell differentiation |
| GO:2001023 | 6.77% | regulation of response to drug |
| GO:0034766 | 6.76% | negative regulation of ion transmembrane transport |
| GO:1904063 | 6.76% | negative regulation of cation transmembrane transport |
| GO:1903034 | 6.75% | regulation of response to wounding |
| GO:2000677 | 6.74% | regulation of transcription regulatory region DNA binding |
| GO:0031328 | 6.74% | positive regulation of cellular biosynthetic process |
| GO:1905952 | 6.72% | regulation of lipid localization |
| GO:0055085 | 6.70% | transmembrane transport |
| GO:0051560 | 6.69% | mitochondrial calcium ion homeostasis |
| GO:0022404 | 6.68% | molting cycle process |
| GO:0007005 | 6.67% | mitochondrion organization |
| GO:0051346 | 6.67% | negative regulation of hydrolase activity |
| GO:1903018 | 6.66% | regulation of glycoprotein metabolic process |
| GO:0071407 | 6.66% | cellular response to organic cyclic compound |
| GO:1903052 | 6.65% | positive regulation of proteolysis involved in cellular protein catabolic process |
| GO:1903201 | 6.65% | regulation of oxidative stress-induced cell death |
| GO:0051093 | 6.63% | negative regulation of developmental process |
| GO:0030004 | 6.63% | cellular monovalent inorganic cation homeostasis |
| GO:0051896 | 6.61% | regulation of protein kinase B signaling |
| GO:0046777 | 6.61% | protein autophosphorylation |
| GO:0010559 | 6.61% | regulation of glycoprotein biosynthetic process |
| GO:0070588 | 6.60% | calcium ion transmembrane transport |
| GO:0051492 | 6.59% | regulation of stress fiber assembly |
| GO:0035150 | 6.59% | regulation of tube size |
| GO:2000147 | 6.57% | positive regulation of cell motility |
| GO:1901800 | 6.57% | positive regulation of proteasomal protein catabolic process |
| GO:0002262 | 6.56% | myeloid cell homeostasis |
| GO:0035296 | 6.54% | regulation of tube diameter |
| GO:0002706 | 6.52% | regulation of lymphocyte mediated immunity |
| GO:2001257 | 6.52% | regulation of cation channel activity |
| GO:0009611 | 6.51% | response to wounding |
| GO:0010976 | 6.51% | positive regulation of neuron projection development |
| GO:0055083 | 6.51% | monovalent inorganic anion homeostasis |
| GO:1900182 | 6.50% | positive regulation of protein localization to nucleus |
| GO:1903706 | 6.50% | regulation of hemopoiesis |
| GO:1902742 | 6.49% | apoptotic process involved in development |
| GO:0097305 | 6.49% | response to alcohol |
| GO:0070727 | 6.49% | cellular macromolecule localization |
| GO:0030888 | 6.48% | regulation of B cell proliferation |
| GO:0097035 | 6.48% | regulation of membrane lipid distribution |
| GO:0045913 | 6.48% | positive regulation of carbohydrate metabolic process |
| GO:1902882 | 6.48% | regulation of response to oxidative stress |
| GO:0033044 | 6.48% | regulation of chromosome organization |
| GO:0040017 | 6.47% | positive regulation of locomotion |
| GO:0009653 | 6.47% | anatomical structure morphogenesis |
| GO:0009991 | 6.46% | response to extracellular stimulus |
| GO:0032515 | 6.43% | negative regulation of phosphoprotein phosphatase activity |
| GO:0045184 | 6.42% | establishment of protein localization |
| GO:0010720 | 6.41% | positive regulation of cell development |
| GO:1901019 | 6.40% | regulation of calcium ion transmembrane transporter activity |
| GO:0008630 | 6.39% | intrinsic apoptotic signaling pathway in response to DNA damage |
| GO:0051966 | 6.39% | regulation of synaptic transmission, glutamatergic |
| GO:0031341 | 6.39% | regulation of cell killing |
| GO:0045785 | 6.39% | positive regulation of cell adhesion |
| GO:0051962 | 6.38% | positive regulation of nervous system development |
| GO:0006796 | 6.36% | phosphate-containing compound metabolic process |
| GO:0098662 | 6.34% | inorganic cation transmembrane transport |
| GO:0031343 | 6.34% | positive regulation of cell killing |
| GO:0060284 | 6.34% | regulation of cell development |
| GO:0061061 | 6.33% | muscle structure development |
| GO:0072657 | 6.33% | protein localization to membrane |
| GO:0010762 | 6.33% | regulation of fibroblast migration |
| GO:0030334 | 6.32% | regulation of cell migration |
| GO:0071705 | 6.32% | nitrogen compound transport |
| GO:0033273 | 6.31% | response to vitamin |
| GO:1902041 | 6.31% | regulation of extrinsic apoptotic signaling pathway via death domain receptors |
| GO:0001894 | 6.30% | tissue homeostasis |
| GO:0043170 | 6.30% | macromolecule metabolic process |
| GO:0071702 | 6.30% | organic substance transport |
| GO:0007009 | 6.29% | plasma membrane organization |
| GO:0050714 | 6.27% | positive regulation of protein secretion |
| GO:0018107 | 6.26% | peptidyl-threonine phosphorylation |
| GO:0051703 | 6.26% | intraspecies interaction between organisms |
| GO:0110053 | 6.22% | regulation of actin filament organization |
| GO:0090317 | 6.20% | negative regulation of intracellular protein transport |
| GO:1902807 | 6.20% | negative regulation of cell cycle G1/S phase transition |
| GO:0032368 | 6.20% | regulation of lipid transport |
| GO:0034613 | 6.19% | cellular protein localization |
| GO:0097553 | 6.19% | calcium ion transmembrane import into cytosol |
| GO:0001782 | 6.19% | B cell homeostasis |
| GO:0045930 | 6.17% | negative regulation of mitotic cell cycle |
| GO:0055088 | 6.17% | lipid homeostasis |
| GO:0030335 | 6.14% | positive regulation of cell migration |
| GO:0010906 | 6.13% | regulation of glucose metabolic process |
| GO:0036293 | 6.13% | response to decreased oxygen levels |
| GO:1903047 | 6.11% | mitotic cell cycle process |
| GO:0045670 | 6.11% | regulation of osteoclast differentiation |
| GO:0051960 | 6.10% | regulation of nervous system development |
| GO:0071364 | 6.10% | cellular response to epidermal growth factor stimulus |
| GO:0044058 | 6.07% | regulation of digestive system process |
| GO:0071674 | 6.06% | mononuclear cell migration |
| GO:0050673 | 6.06% | epithelial cell proliferation |
| GO:0070098 | 6.05% | chemokine-mediated signaling pathway |
| GO:0030198 | 6.05% | extracellular matrix organization |
| GO:0003018 | 6.05% | vascular process in circulatory system |
| GO:0032007 | 6.04% | negative regulation of TOR signaling |
| GO:0043062 | 6.04% | extracellular structure organization |
| GO:0018210 | 6.03% | peptidyl-threonine modification |
| GO:0070059 | 6.03% | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress |
| GO:0032091 | 6.02% | negative regulation of protein binding |
| GO:0032872 | 6.01% | regulation of stress-activated MAPK cascade |
| GO:0016525 | 6.01% | negative regulation of angiogenesis |
| GO:0030111 | 6.00% | regulation of Wnt signaling pathway |
| GO:0006940 | 6.00% | regulation of smooth muscle contraction |
| GO:0060135 | 5.99% | maternal process involved in female pregnancy |
| GO:0045921 | 5.99% | positive regulation of exocytosis |
| GO:1903670 | 5.96% | regulation of sprouting angiogenesis |
| GO:0032101 | 5.95% | regulation of response to external stimulus |
| GO:2000181 | 5.95% | negative regulation of blood vessel morphogenesis |
| GO:0009266 | 5.95% | response to temperature stimulus |
| GO:2000106 | 5.93% | regulation of leukocyte apoptotic process |
| GO:1903508 | 5.93% | positive regulation of nucleic acid-templated transcription |
| GO:1902680 | 5.93% | positive regulation of RNA biosynthetic process |
| GO:1901888 | 5.92% | regulation of cell junction assembly |
| GO:0001910 | 5.91% | regulation of leukocyte mediated cytotoxicity |
| GO:0098659 | 5.91% | inorganic cation import across plasma membrane |
| GO:0003012 | 5.90% | muscle system process |
| GO:0032092 | 5.89% | positive regulation of protein binding |
| GO:0001936 | 5.88% | regulation of endothelial cell proliferation |
| GO:0032006 | 5.87% | regulation of TOR signaling |
| GO:0050867 | 5.86% | positive regulation of cell activation |
| GO:0098660 | 5.85% | inorganic ion transmembrane transport |
| GO:0062013 | 5.85% | positive regulation of small molecule metabolic process |
| GO:0007346 | 5.84% | regulation of mitotic cell cycle |
| GO:0045935 | 5.84% | positive regulation of nucleobase-containing compound metabolic process |
| GO:0007584 | 5.83% | response to nutrient |
| GO:0071347 | 5.83% | cellular response to interleukin-1 |
| GO:0071363 | 5.83% | cellular response to growth factor stimulus |
| GO:0048609 | 5.82% | multicellular organismal reproductive process |
| GO:0002548 | 5.80% | monocyte chemotaxis |
| GO:0050778 | 5.80% | positive regulation of immune response |
| GO:1903364 | 5.80% | positive regulation of cellular protein catabolic process |
| GO:0001954 | 5.79% | positive regulation of cell-matrix adhesion |
| GO:0045893 | 5.79% | positive regulation of transcription, DNA-templated |
| GO:0051705 | 5.79% | multi-organism behavior |
| GO:0001938 | 5.79% | positive regulation of endothelial cell proliferation |
| GO:0009792 | 5.77% | embryo development ending in birth or egg hatching |
| GO:0070050 | 5.76% | neuron cellular homeostasis |
| GO:0051254 | 5.76% | positive regulation of RNA metabolic process |
| GO:0035308 | 5.76% | negative regulation of protein dephosphorylation |
| GO:1901988 | 5.74% | negative regulation of cell cycle phase transition |
| GO:0001919 | 5.74% | regulation of receptor recycling |
| GO:0034114 | 5.70% | regulation of heterotypic cell-cell adhesion |
| GO:0070302 | 5.70% | regulation of stress-activated protein kinase signaling cascade |
| GO:0007200 | 5.69% | phospholipase C-activating G protein-coupled receptor signaling pathway |
| GO:0062014 | 5.68% | negative regulation of small molecule metabolic process |
| GO:0010155 | 5.68% | regulation of proton transport |
| GO:0042593 | 5.68% | glucose homeostasis |
| GO:2001258 | 5.68% | negative regulation of cation channel activity |
| GO:0022409 | 5.67% | positive regulation of cell-cell adhesion |
| GO:0042110 | 5.67% | T cell activation |
| GO:0002699 | 5.67% | positive regulation of immune effector process |
| GO:0035065 | 5.67% | regulation of histone acetylation |
| GO:0022402 | 5.66% | cell cycle process |
| GO:0030100 | 5.66% | regulation of endocytosis |
| GO:0070482 | 5.66% | response to oxygen levels |
| GO:0006936 | 5.66% | muscle contraction |
| GO:0002685 | 5.64% | regulation of leukocyte migration |
| GO:1905476 | 5.64% | negative regulation of protein localization to membrane |
| GO:0001953 | 5.64% | negative regulation of cell-matrix adhesion |
| GO:0010675 | 5.63% | regulation of cellular carbohydrate metabolic process |
| GO:1903393 | 5.63% | positive regulation of adherens junction organization |
| GO:0035094 | 5.63% | response to nicotine |
| GO:0048534 | 5.63% | hematopoietic or lymphoid organ development |
| GO:1900407 | 5.62% | regulation of cellular response to oxidative stress |
| GO:2001038 | 5.62% | regulation of cellular response to drug |
| GO:0033500 | 5.61% | carbohydrate homeostasis |
| GO:1903170 | 5.60% | negative regulation of calcium ion transmembrane transport |
| GO:0046330 | 5.58% | positive regulation of JNK cascade |
| GO:2000351 | 5.58% | regulation of endothelial cell apoptotic process |
| GO:0007599 | 5.58% | hemostasis |
| GO:1903039 | 5.57% | positive regulation of leukocyte cell-cell adhesion |
| GO:0010922 | 5.55% | positive regulation of phosphatase activity |
| GO:1904035 | 5.55% | regulation of epithelial cell apoptotic process |
| GO:0043462 | 5.54% | regulation of ATPase activity |
| GO:1904037 | 5.52% | positive regulation of epithelial cell apoptotic process |
| GO:0043902 | 5.51% | positive regulation of multi-organism process |
| GO:0006997 | 5.49% | nucleus organization |
| GO:0051704 | 5.49% | multi-organism process |
| GO:0098609 | 5.48% | cell-cell adhesion |
| GO:0051590 | 5.48% | positive regulation of neurotransmitter transport |
| GO:0002700 | 5.47% | regulation of production of molecular mediator of immune response |
| GO:0099587 | 5.46% | inorganic ion import across plasma membrane |
| GO:0010557 | 5.45% | positive regulation of macromolecule biosynthetic process |
| GO:0000413 | 5.45% | protein peptidyl-prolyl isomerization |
| GO:0032496 | 5.44% | response to lipopolysaccharide |
| GO:0002697 | 5.44% | regulation of immune effector process |
| GO:2000649 | 5.43% | regulation of sodium ion transmembrane transporter activity |
| GO:0032355 | 5.42% | response to estradiol |
| GO:0033135 | 5.42% | regulation of peptidyl-serine phosphorylation |
| GO:0048285 | 5.42% | organelle fission |
| GO:0009416 | 5.42% | response to light stimulus |
| GO:1901991 | 5.39% | negative regulation of mitotic cell cycle phase transition |
| GO:1903779 | 5.38% | regulation of cardiac conduction |
| GO:0001666 | 5.38% | response to hypoxia |
| GO:0010628 | 5.37% | positive regulation of gene expression |
| GO:0010595 | 5.37% | positive regulation of endothelial cell migration |
| GO:0007275 | 5.37% | multicellular organism development |
| GO:1902305 | 5.36% | regulation of sodium ion transmembrane transport |
| GO:0051224 | 5.36% | negative regulation of protein transport |
| GO:0061041 | 5.35% | regulation of wound healing |
| GO:0000280 | 5.35% | nuclear division |
| GO:0006955 | 5.35% | immune response |
| GO:0022604 | 5.34% | regulation of cell morphogenesis |
| GO:0006468 | 5.34% | protein phosphorylation |
| GO:0045619 | 5.33% | regulation of lymphocyte differentiation |
| GO:0002819 | 5.32% | regulation of adaptive immune response |
| GO:0046486 | 5.32% | glycerolipid metabolic process |
| GO:0071375 | 5.31% | cellular response to peptide hormone stimulus |
| GO:0060193 | 5.31% | positive regulation of lipase activity |
| GO:0048232 | 5.31% | male gamete generation |
| GO:0043281 | 5.30% | regulation of cysteine-type endopeptidase activity involved in apoptotic process |
| GO:0051897 | 5.27% | positive regulation of protein kinase B signaling |
| GO:0007264 | 5.27% | small GTPase mediated signal transduction |
| GO:0010665 | 5.26% | regulation of cardiac muscle cell apoptotic process |
| GO:0010039 | 5.26% | response to iron ion |
| GO:0017157 | 5.26% | regulation of exocytosis |
| GO:0032376 | 5.25% | positive regulation of cholesterol transport |
| GO:0006109 | 5.25% | regulation of carbohydrate metabolic process |
| GO:0042311 | 5.25% | vasodilation |
| GO:0009895 | 5.24% | negative regulation of catabolic process |
| GO:0060401 | 5.22% | cytosolic calcium ion transport |
| GO:0060761 | 5.22% | negative regulation of response to cytokine stimulus |
| GO:0003006 | 5.21% | developmental process involved in reproduction |
| GO:0050728 | 5.21% | negative regulation of inflammatory response |
| GO:0010923 | 5.20% | negative regulation of phosphatase activity |
| GO:0070542 | 5.20% | response to fatty acid |
| GO:0051099 | 5.20% | positive regulation of binding |
| GO:0002088 | 5.19% | lens development in camera-type eye |
| GO:0045580 | 5.18% | regulation of T cell differentiation |
| GO:1904030 | 5.18% | negative regulation of cyclin-dependent protein kinase activity |
| GO:0001775 | 5.18% | cell activation |
| GO:0050878 | 5.17% | regulation of body fluid levels |
| GO:0019538 | 5.16% | protein metabolic process |
| GO:0030858 | 5.16% | positive regulation of epithelial cell differentiation |
| GO:0046328 | 5.15% | regulation of JNK cascade |
| GO:0002237 | 5.14% | response to molecule of bacterial origin |
| GO:0001942 | 5.14% | hair follicle development |
| GO:0043473 | 5.14% | pigmentation |
| GO:0070509 | 5.13% | calcium ion import |
| GO:1900046 | 5.13% | regulation of hemostasis |
| GO:0010288 | 5.12% | response to lead ion |
| GO:0048538 | 5.12% | thymus development |
| GO:0001101 | 5.10% | response to acid chemical |
| GO:0051283 | 5.10% | negative regulation of sequestering of calcium ion |
| GO:1903010 | 5.09% | regulation of bone development |
| GO:2000241 | 5.09% | regulation of reproductive process |
| GO:0034622 | 5.07% | cellular protein-containing complex assembly |
| GO:0070373 | 5.07% | negative regulation of ERK1 and ERK2 cascade |
| GO:0070661 | 5.07% | leukocyte proliferation |
| GO:1904950 | 5.07% | negative regulation of establishment of protein localization |
| GO:0032102 | 5.07% | negative regulation of response to external stimulus |
| GO:1900371 | 5.06% | regulation of purine nucleotide biosynthetic process |
| GO:0016048 | 5.06% | detection of temperature stimulus |
| GO:0031330 | 5.05% | negative regulation of cellular catabolic process |
| GO:2001244 | 5.04% | positive regulation of intrinsic apoptotic signaling pathway |
| GO:0010662 | 5.04% | regulation of striated muscle cell apoptotic process |
| GO:0007283 | 5.03% | spermatogenesis |
| GO:0010765 | 5.03% | positive regulation of sodium ion transport |
| GO:0031929 | 5.03% | TOR signaling |
| GO:1905898 | 5.03% | positive regulation of response to endoplasmic reticulum stress |
| GO:0050777 | 5.02% | negative regulation of immune response |
| GO:0010948 | 5.02% | negative regulation of cell cycle process |
| GO:0001952 | 5.02% | regulation of cell-matrix adhesion |
| GO:0050679 | 5.02% | positive regulation of epithelial cell proliferation |
| GO:1901016 | 5.01% | regulation of potassium ion transmembrane transporter activity |
| GO:0010447 | 5.01% | response to acidic pH |
| GO:0048870 | 5.00% | cell motility |
| GO:0032371 | 5.00% | regulation of sterol transport |
| GO:0007186 | 5.00% | G protein-coupled receptor signaling pathway |
| GO:1903531 | 4.99% | negative regulation of secretion by cell |
| GO:0090109 | 4.99% | regulation of cell-substrate junction assembly |
| GO:0051881 | 4.98% | regulation of mitochondrial membrane potential |
| GO:0097237 | 4.98% | cellular response to toxic substance |
| GO:1901215 | 4.97% | negative regulation of neuron death |
| GO:0007006 | 4.97% | mitochondrial membrane organization |
| GO:0034341 | 4.97% | response to interferon-gamma |
| GO:0001776 | 4.97% | leukocyte homeostasis |
| GO:0010799 | 4.96% | regulation of peptidyl-threonine phosphorylation |
| GO:0010669 | 4.96% | epithelial structure maintenance |
| GO:0010634 | 4.95% | positive regulation of epithelial cell migration |
| GO:0071346 | 4.95% | cellular response to interferon-gamma |
| GO:0032373 | 4.95% | positive regulation of sterol transport |
| GO:0050769 | 4.94% | positive regulation of neurogenesis |
| GO:0042149 | 4.94% | cellular response to glucose starvation |
| GO:0035305 | 4.94% | negative regulation of dephosphorylation |
| GO:0033628 | 4.94% | regulation of cell adhesion mediated by integrin |
| GO:0009268 | 4.93% | response to pH |
| GO:0000226 | 4.93% | microtubule cytoskeleton organization |
| GO:0045806 | 4.92% | negative regulation of endocytosis |
| GO:0071774 | 4.90% | response to fibroblast growth factor |
| GO:0030193 | 4.90% | regulation of blood coagulation |
| GO:0016477 | 4.90% | cell migration |
| GO:1901222 | 4.89% | regulation of NIK/NF-kappaB signaling |
| GO:1902903 | 4.89% | regulation of supramolecular fiber organization |
| GO:0009411 | 4.89% | response to UV |
| GO:0045664 | 4.89% | regulation of neuron differentiation |
| GO:0098739 | 4.88% | import across plasma membrane |
| GO:0098542 | 4.87% | defense response to other organism |
| GO:0046474 | 4.86% | glycerophospholipid biosynthetic process |
| GO:0051209 | 4.86% | release of sequestered calcium ion into cytosol |
| GO:0002260 | 4.86% | lymphocyte homeostasis |
| GO:0048732 | 4.86% | gland development |
| GO:0044255 | 4.86% | cellular lipid metabolic process |
| GO:0090277 | 4.86% | positive regulation of peptide hormone secretion |
| GO:0051893 | 4.86% | regulation of focal adhesion assembly |
| GO:0010821 | 4.85% | regulation of mitochondrion organization |
| GO:0009612 | 4.84% | response to mechanical stimulus |
| GO:0055067 | 4.84% | monovalent inorganic cation homeostasis |
| GO:0042060 | 4.84% | wound healing |
| GO:0002702 | 4.84% | positive regulation of production of molecular mediator of immune response |
| GO:0002009 | 4.83% | morphogenesis of an epithelium |
| GO:0072659 | 4.83% | protein localization to plasma membrane |
| GO:0010738 | 4.83% | regulation of protein kinase A signaling |
| GO:0097755 | 4.83% | positive regulation of blood vessel diameter |
| GO:0032570 | 4.82% | response to progesterone |
| GO:0015031 | 4.82% | protein transport |
| GO:0003013 | 4.81% | circulatory system process |
| GO:0043267 | 4.80% | negative regulation of potassium ion transport |
| GO:1903203 | 4.79% | regulation of oxidative stress-induced neuron death |
| GO:0051707 | 4.79% | response to other organism |
| GO:0046902 | 4.79% | regulation of mitochondrial membrane permeability |
| GO:0045666 | 4.78% | positive regulation of neuron differentiation |
| GO:2001020 | 4.77% | regulation of response to DNA damage stimulus |
| GO:0010719 | 4.77% | negative regulation of epithelial to mesenchymal transition |
| GO:0030808 | 4.77% | regulation of nucleotide biosynthetic process |
| GO:1902905 | 4.76% | positive regulation of supramolecular fiber organization |
| GO:0019217 | 4.75% | regulation of fatty acid metabolic process |
| GO:0006650 | 4.75% | glycerophospholipid metabolic process |
| GO:0016242 | 4.75% | negative regulation of macroautophagy |
| GO:0060828 | 4.74% | regulation of canonical Wnt signaling pathway |
| GO:0070301 | 4.73% | cellular response to hydrogen peroxide |
| GO:0042176 | 4.73% | regulation of protein catabolic process |
| GO:0030168 | 4.72% | platelet activation |
| GO:0050818 | 4.72% | regulation of coagulation |
| GO:1901655 | 4.72% | cellular response to ketone |
| GO:0008654 | 4.71% | phospholipid biosynthetic process |
| GO:0050773 | 4.71% | regulation of dendrite development |
| GO:0019935 | 4.71% | cyclic-nucleotide-mediated signaling |
| GO:0043268 | 4.70% | positive regulation of potassium ion transport |
| GO:2001242 | 4.69% | regulation of intrinsic apoptotic signaling pathway |
| GO:0002028 | 4.69% | regulation of sodium ion transport |
| GO:0031347 | 4.68% | regulation of defense response |
| GO:0050732 | 4.68% | negative regulation of peptidyl-tyrosine phosphorylation |
| GO:1902107 | 4.67% | positive regulation of leukocyte differentiation |
| GO:2001236 | 4.67% | regulation of extrinsic apoptotic signaling pathway |
| GO:0001960 | 4.66% | negative regulation of cytokine-mediated signaling pathway |
| GO:0002761 | 4.66% | regulation of myeloid leukocyte differentiation |
| GO:0002821 | 4.66% | positive regulation of adaptive immune response |
| GO:0007276 | 4.66% | gamete generation |
| GO:0031333 | 4.66% | negative regulation of protein complex assembly |
| GO:0045596 | 4.65% | negative regulation of cell differentiation |
| GO:0046824 | 4.64% | positive regulation of nucleocytoplasmic transport |
| GO:0032989 | 4.64% | cellular component morphogenesis |
| GO:0060402 | 4.64% | calcium ion transport into cytosol |
| GO:0048814 | 4.63% | regulation of dendrite morphogenesis |
| GO:0031175 | 4.63% | neuron projection development |
| GO:0046889 | 4.63% | positive regulation of lipid biosynthetic process |
| GO:0045017 | 4.63% | glycerolipid biosynthetic process |
| GO:0035418 | 4.63% | protein localization to synapse |
| GO:0030029 | 4.61% | actin filament-based process |
| GO:0044344 | 4.60% | cellular response to fibroblast growth factor stimulus |
| GO:0030036 | 4.60% | actin cytoskeleton organization |
| GO:0071236 | 4.60% | cellular response to antibiotic |
| GO:0040011 | 4.60% | locomotion |
| GO:0061099 | 4.57% | negative regulation of protein tyrosine kinase activity |
| GO:0050767 | 4.57% | regulation of neurogenesis |
| GO:0048729 | 4.56% | tissue morphogenesis |
| GO:0031960 | 4.56% | response to corticosteroid |
| GO:2000134 | 4.55% | negative regulation of G1/S transition of mitotic cell cycle |
| GO:0051092 | 4.54% | positive regulation of NF-kappaB transcription factor activity |
| GO:0019216 | 4.54% | regulation of lipid metabolic process |
| GO:0010812 | 4.54% | negative regulation of cell-substrate adhesion |
| GO:0034599 | 4.53% | cellular response to oxidative stress |
| GO:1990778 | 4.53% | protein localization to cell periphery |
| GO:2000758 | 4.52% | positive regulation of peptidyl-lysine acetylation |
| GO:0016050 | 4.52% | vesicle organization |
| GO:0010508 | 4.52% | positive regulation of autophagy |
| GO:0051101 | 4.52% | regulation of DNA binding |
| GO:1901343 | 4.51% | negative regulation of vasculature development |
| GO:0071277 | 4.51% | cellular response to calcium ion |
| GO:0019637 | 4.51% | organophosphate metabolic process |
| GO:0007202 | 4.50% | activation of phospholipase C activity |
| GO:1903205 | 4.50% | regulation of hydrogen peroxide-induced cell death |
| GO:0001763 | 4.50% | morphogenesis of a branching structure |
| GO:0008637 | 4.50% | apoptotic mitochondrial changes |
| GO:2000179 | 4.50% | positive regulation of neural precursor cell proliferation |
| GO:0016241 | 4.50% | regulation of macroautophagy |
| GO:0018209 | 4.50% | peptidyl-serine modification |
| GO:0010507 | 4.49% | negative regulation of autophagy |
| GO:0051602 | 4.49% | response to electrical stimulus |
| GO:0031063 | 4.48% | regulation of histone deacetylation |
| GO:0098900 | 4.48% | regulation of action potential |
| GO:0007600 | 4.46% | sensory perception |
| GO:0045732 | 4.45% | positive regulation of protein catabolic process |
| GO:0031348 | 4.45% | negative regulation of defense response |
| GO:0033137 | 4.45% | negative regulation of peptidyl-serine phosphorylation |
| GO:0051453 | 4.44% | regulation of intracellular pH |
| GO:0009056 | 4.44% | catabolic process |
| GO:0006909 | 4.44% | phagocytosis |
| GO:0051606 | 4.44% | detection of stimulus |
| GO:0030856 | 4.44% | regulation of epithelial cell differentiation |
| GO:0048010 | 4.43% | vascular endothelial growth factor receptor signaling pathway |
| GO:0034976 | 4.43% | response to endoplasmic reticulum stress |
| GO:0051607 | 4.43% | defense response to virus |
| GO:0042594 | 4.43% | response to starvation |
| GO:0070925 | 4.41% | organelle assembly |
| GO:2001024 | 4.41% | negative regulation of response to drug |
| GO:0071496 | 4.41% | cellular response to external stimulus |
| GO:0043277 | 4.41% | apoptotic cell clearance |
| GO:0034110 | 4.41% | regulation of homotypic cell-cell adhesion |
| GO:0071398 | 4.40% | cellular response to fatty acid |
| GO:0071216 | 4.40% | cellular response to biotic stimulus |
| GO:1901985 | 4.40% | positive regulation of protein acetylation |
| GO:0050727 | 4.39% | regulation of inflammatory response |
| GO:0010863 | 4.39% | positive regulation of phospholipase C activity |
| GO:0090407 | 4.38% | organophosphate biosynthetic process |
| GO:0048468 | 4.37% | cell development |
| GO:0032374 | 4.37% | regulation of cholesterol transport |
| GO:1904029 | 4.37% | regulation of cyclin-dependent protein kinase activity |
| GO:0051271 | 4.36% | negative regulation of cellular component movement |
| GO:0071470 | 4.36% | cellular response to osmotic stress |
| GO:0048041 | 4.36% | focal adhesion assembly |
| GO:1903307 | 4.35% | positive regulation of regulated secretory pathway |
| GO:0060070 | 4.34% | canonical Wnt signaling pathway |
| GO:2000171 | 4.34% | negative regulation of dendrite development |
| GO:0015833 | 4.33% | peptide transport |
| GO:0090066 | 4.33% | regulation of anatomical structure size |
| GO:0051302 | 4.32% | regulation of cell division |
| GO:0007268 | 4.32% | chemical synaptic transmission |
| GO:0043491 | 4.32% | protein kinase B signaling |
| GO:0002696 | 4.31% | positive regulation of leukocyte activation |
| GO:0009743 | 4.31% | response to carbohydrate |
| GO:0050873 | 4.31% | brown fat cell differentiation |
| GO:0032869 | 4.31% | cellular response to insulin stimulus |
| GO:0032436 | 4.30% | positive regulation of proteasomal ubiquitin-dependent protein catabolic process |
| GO:0038179 | 4.30% | neurotrophin signaling pathway |
| GO:0044267 | 4.30% | cellular protein metabolic process |
| GO:0046649 | 4.28% | lymphocyte activation |
| GO:0009887 | 4.28% | animal organ morphogenesis |
| GO:0009408 | 4.27% | response to heat |
| GO:0030195 | 4.27% | negative regulation of blood coagulation |
| GO:0043255 | 4.27% | regulation of carbohydrate biosynthetic process |
| GO:0002705 | 4.27% | positive regulation of leukocyte mediated immunity |
| GO:0051384 | 4.27% | response to glucocorticoid |
| GO:0009790 | 4.26% | embryo development |
| GO:0070229 | 4.26% | negative regulation of lymphocyte apoptotic process |
| GO:0040013 | 4.26% | negative regulation of locomotion |
| GO:0006906 | 4.26% | vesicle fusion |
| GO:0032874 | 4.25% | positive regulation of stress-activated MAPK cascade |
| GO:0051048 | 4.25% | negative regulation of secretion |
| GO:0061178 | 4.24% | regulation of insulin secretion involved in cellular response to glucose stimulus |
| GO:0098916 | 4.23% | anterograde trans-synaptic signaling |
| GO:0071383 | 4.23% | cellular response to steroid hormone stimulus |
| GO:0008286 | 4.22% | insulin receptor signaling pathway |
| GO:0006140 | 4.21% | regulation of nucleotide metabolic process |
| GO:0035774 | 4.21% | positive regulation of insulin secretion involved in cellular response to glucose stimulus |
| GO:2000146 | 4.21% | negative regulation of cell motility |
| GO:0061138 | 4.21% | morphogenesis of a branching epithelium |
| GO:0022406 | 4.21% | membrane docking |
| GO:1905330 | 4.19% | regulation of morphogenesis of an epithelium |
| GO:0043536 | 4.19% | positive regulation of blood vessel endothelial cell migration |
| GO:0016310 | 4.18% | phosphorylation |
| GO:0050817 | 4.18% | coagulation |
| GO:0070570 | 4.18% | regulation of neuron projection regeneration |
| GO:0006629 | 4.18% | lipid metabolic process |
| GO:1900120 | 4.17% | regulation of receptor binding |
| GO:0032868 | 4.16% | response to insulin |
| GO:0007045 | 4.16% | cell-substrate adherens junction assembly |
| GO:0031349 | 4.16% | positive regulation of defense response |
| GO:0046825 | 4.16% | regulation of protein export from nucleus |
| GO:1902883 | 4.14% | negative regulation of response to oxidative stress |
| GO:0090330 | 4.13% | regulation of platelet aggregation |
| GO:0010769 | 4.13% | regulation of cell morphogenesis involved in differentiation |
| GO:0032469 | 4.13% | endoplasmic reticulum calcium ion homeostasis |
| GO:0010656 | 4.12% | negative regulation of muscle cell apoptotic process |
| GO:0046822 | 4.11% | regulation of nucleocytoplasmic transport |
| GO:0031954 | 4.11% | positive regulation of protein autophosphorylation |
| GO:0006644 | 4.11% | phospholipid metabolic process |
| GO:0071901 | 4.10% | negative regulation of protein serine/threonine kinase activity |
| GO:0043534 | 4.10% | blood vessel endothelial cell migration |
| GO:0040008 | 4.10% | regulation of growth |
| GO:1901987 | 4.10% | regulation of cell cycle phase transition |
| GO:2000108 | 4.09% | positive regulation of leukocyte apoptotic process |
| GO:0031346 | 4.08% | positive regulation of cell projection organization |
| GO:0014904 | 4.07% | myotube cell development |
| GO:0071902 | 4.07% | positive regulation of protein serine/threonine kinase activity |
| GO:1902806 | 4.07% | regulation of cell cycle G1/S phase transition |
| GO:1903391 | 4.07% | regulation of adherens junction organization |
| GO:0042886 | 4.06% | amide transport |
| GO:0030178 | 4.06% | negative regulation of Wnt signaling pathway |
| GO:1900047 | 4.06% | negative regulation of hemostasis |
| GO:1903321 | 4.06% | negative regulation of protein modification by small protein conjugation or removal |
| GO:0043502 | 4.06% | regulation of muscle adaptation |
| GO:0002718 | 4.05% | regulation of cytokine production involved in immune response |
| GO:0046883 | 4.04% | regulation of hormone secretion |
| GO:0006111 | 4.04% | regulation of gluconeogenesis |
| GO:0045321 | 4.04% | leukocyte activation |
| GO:1901184 | 4.04% | regulation of ERBB signaling pathway |
| GO:0061025 | 4.03% | membrane fusion |
| GO:0045471 | 4.03% | response to ethanol |
| GO:0045637 | 4.02% | regulation of myeloid cell differentiation |
| GO:0035690 | 4.02% | cellular response to drug |
| GO:0043434 | 4.01% | response to peptide hormone |
| GO:0007389 | 4.01% | pattern specification process |
| GO:0046903 | 4.01% | secretion |
| GO:0009581 | 4.01% | detection of external stimulus |
| GO:0007266 | 4.01% | Rho protein signal transduction |
| GO:0040007 | 4.01% | growth |
| GO:0050680 | 4.01% | negative regulation of epithelial cell proliferation |
| GO:0035023 | 4.01% | regulation of Rho protein signal transduction |
| GO:0001819 | 4.00% | positive regulation of cytokine production |
| GO:0035567 | 4.00% | non-canonical Wnt signaling pathway |
| GO:0097421 | 4.00% | liver regeneration |
| GO:0071322 | 4.00% | cellular response to carbohydrate stimulus |
| GO:1901990 | 3.99% | regulation of mitotic cell cycle phase transition |
| GO:0042098 | 3.99% | T cell proliferation |
| GO:0048511 | 3.99% | rhythmic process |
| GO:0090311 | 3.98% | regulation of protein deacetylation |
| GO:0043200 | 3.98% | response to amino acid |
| GO:0090559 | 3.97% | regulation of membrane permeability |
| GO:0090199 | 3.97% | regulation of release of cytochrome c from mitochondria |
| GO:0002831 | 3.97% | regulation of response to biotic stimulus |
| GO:0043412 | 3.97% | macromolecule modification |
| GO:0032956 | 3.97% | regulation of actin cytoskeleton organization |
| GO:0051452 | 3.96% | intracellular pH reduction |
| GO:0030099 | 3.96% | myeloid cell differentiation |
| GO:0030182 | 3.95% | neuron differentiation |
| GO:0010565 | 3.95% | regulation of cellular ketone metabolic process |
| GO:0030641 | 3.94% | regulation of cellular pH |
| GO:0099536 | 3.93% | synaptic signaling |
| GO:0007215 | 3.93% | glutamate receptor signaling pathway |
| GO:0048771 | 3.92% | tissue remodeling |
| GO:0044260 | 3.92% | cellular macromolecule metabolic process |
| GO:0007265 | 3.92% | Ras protein signal transduction |
| GO:0050850 | 3.92% | positive regulation of calcium-mediated signaling |
| GO:0045185 | 3.90% | maintenance of protein location |
| GO:0035914 | 3.89% | skeletal muscle cell differentiation |
| GO:0098657 | 3.89% | import into cell |
| GO:1903050 | 3.88% | regulation of proteolysis involved in cellular protein catabolic process |
| GO:0010664 | 3.88% | negative regulation of striated muscle cell apoptotic process |
| GO:0006879 | 3.88% | cellular iron ion homeostasis |
| GO:0019933 | 3.88% | cAMP-mediated signaling |
| GO:0070304 | 3.87% | positive regulation of stress-activated protein kinase signaling cascade |
| GO:0045933 | 3.87% | positive regulation of muscle contraction |
| GO:1903362 | 3.87% | regulation of cellular protein catabolic process |
| GO:0030336 | 3.87% | negative regulation of cell migration |
| GO:0050764 | 3.86% | regulation of phagocytosis |
| GO:0071229 | 3.85% | cellular response to acid chemical |
| GO:0051056 | 3.85% | regulation of small GTPase mediated signal transduction |
| GO:1903707 | 3.85% | negative regulation of hemopoiesis |
| GO:1903747 | 3.85% | regulation of establishment of protein localization to mitochondrion |
| GO:0001935 | 3.85% | endothelial cell proliferation |
| GO:0043900 | 3.85% | regulation of multi-organism process |
| GO:0006323 | 3.84% | DNA packaging |
| GO:0007596 | 3.84% | blood coagulation |
| GO:0033081 | 3.84% | regulation of T cell differentiation in thymus |
| GO:0010717 | 3.83% | regulation of epithelial to mesenchymal transition |
| GO:0043392 | 3.83% | negative regulation of DNA binding |
| GO:0005979 | 3.82% | regulation of glycogen biosynthetic process |
| GO:0043524 | 3.82% | negative regulation of neuron apoptotic process |
| GO:0006376 | 3.82% | mRNA splice site selection |
| GO:0042058 | 3.81% | regulation of epidermal growth factor receptor signaling pathway |
| GO:2000060 | 3.81% | positive regulation of ubiquitin-dependent protein catabolic process |
| GO:0021766 | 3.81% | hippocampus development |
| GO:0002791 | 3.80% | regulation of peptide secretion |
| GO:0009617 | 3.79% | response to bacterium |
| GO:0030261 | 3.79% | chromosome condensation |
| GO:0032103 | 3.79% | positive regulation of response to external stimulus |
| GO:0009888 | 3.79% | tissue development |
| GO:0048679 | 3.78% | regulation of axon regeneration |
| GO:0034122 | 3.78% | negative regulation of toll-like receptor signaling pathway |
| GO:0099601 | 3.78% | regulation of neurotransmitter receptor activity |
| GO:1900542 | 3.78% | regulation of purine nucleotide metabolic process |
| GO:0031100 | 3.78% | animal organ regeneration |
| GO:0043405 | 3.77% | regulation of MAP kinase activity |
| GO:1901224 | 3.77% | positive regulation of NIK/NF-kappaB signaling |
| GO:0010165 | 3.77% | response to X-ray |
| GO:0010660 | 3.77% | regulation of muscle cell apoptotic process |
| GO:0030968 | 3.77% | endoplasmic reticulum unfolded protein response |
| GO:0044248 | 3.76% | cellular catabolic process |
| GO:1904376 | 3.76% | negative regulation of protein localization to cell periphery |
| GO:0000278 | 3.76% | mitotic cell cycle |
| GO:0030900 | 3.76% | forebrain development |
| GO:0007423 | 3.76% | sensory organ development |
| GO:0043279 | 3.75% | response to alkaloid |
| GO:0045851 | 3.75% | pH reduction |
| GO:0006813 | 3.75% | potassium ion transport |
| GO:0002709 | 3.75% | regulation of T cell mediated immunity |
| GO:0010543 | 3.74% | regulation of platelet activation |
| GO:2001234 | 3.74% | negative regulation of apoptotic signaling pathway |
| GO:0014013 | 3.74% | regulation of gliogenesis |
| GO:0046890 | 3.74% | regulation of lipid biosynthetic process |
| GO:0050819 | 3.73% | negative regulation of coagulation |
| GO:1900273 | 3.72% | positive regulation of long-term synaptic potentiation |
| GO:0010667 | 3.72% | negative regulation of cardiac muscle cell apoptotic process |
| GO:0002704 | 3.71% | negative regulation of leukocyte mediated immunity |
| GO:0018193 | 3.71% | peptidyl-amino acid modification |
| GO:1905332 | 3.71% | positive regulation of morphogenesis of an epithelium |
| GO:0002698 | 3.71% | negative regulation of immune effector process |
| GO:0009582 | 3.71% | detection of abiotic stimulus |
| GO:0090288 | 3.70% | negative regulation of cellular response to growth factor stimulus |
| GO:1903035 | 3.70% | negative regulation of response to wounding |
| GO:0032024 | 3.69% | positive regulation of insulin secretion |
| GO:0043535 | 3.69% | regulation of blood vessel endothelial cell migration |
| GO:2000772 | 3.69% | regulation of cellular senescence |
| GO:1903036 | 3.68% | positive regulation of response to wounding |
| GO:0048598 | 3.67% | embryonic morphogenesis |
| GO:0035066 | 3.67% | positive regulation of histone acetylation |
| GO:0006457 | 3.66% | protein folding |
| GO:1901031 | 3.66% | regulation of response to reactive oxygen species |
| GO:0016192 | 3.65% | vesicle-mediated transport |
| GO:1904018 | 3.65% | positive regulation of vasculature development |
| GO:0001764 | 3.64% | neuron migration |
| GO:0036211 | 3.64% | protein modification process |
| GO:0051153 | 3.64% | regulation of striated muscle cell differentiation |
| GO:0002707 | 3.64% | negative regulation of lymphocyte mediated immunity |
| GO:0006325 | 3.64% | chromatin organization |
| GO:0032677 | 3.63% | regulation of interleukin-8 production |
| GO:0045926 | 3.63% | negative regulation of growth |
| GO:0032925 | 3.62% | regulation of activin receptor signaling pathway |
| GO:0034105 | 3.62% | positive regulation of tissue remodeling |
| GO:0032757 | 3.61% | positive regulation of interleukin-8 production |
| GO:0051569 | 3.61% | regulation of histone H3-K4 methylation |
| GO:0031065 | 3.60% | positive regulation of histone deacetylation |
| GO:0072331 | 3.60% | signal transduction by p53 class mediator |
| GO:0034614 | 3.58% | cellular response to reactive oxygen species |
| GO:0060456 | 3.58% | positive regulation of digestive system process |
| GO:0060393 | 3.58% | regulation of pathway-restricted SMAD protein phosphorylation |
| GO:0010810 | 3.58% | regulation of cell-substrate adhesion |
| GO:0048678 | 3.58% | response to axon injury |
| GO:0030316 | 3.57% | osteoclast differentiation |
| GO:0061045 | 3.57% | negative regulation of wound healing |
| GO:0061217 | 3.57% | regulation of mesonephros development |
| GO:0006939 | 3.56% | smooth muscle contraction |
| GO:0001501 | 3.56% | skeletal system development |
| GO:2000177 | 3.56% | regulation of neural precursor cell proliferation |
| GO:0007188 | 3.55% | adenylate cyclase-modulating G protein-coupled receptor signaling pathway |
| GO:2000107 | 3.55% | negative regulation of leukocyte apoptotic process |
| GO:0051493 | 3.55% | regulation of cytoskeleton organization |
| GO:0071478 | 3.55% | cellular response to radiation |
| GO:0017148 | 3.54% | negative regulation of translation |
| GO:0006464 | 3.54% | cellular protein modification process |
| GO:0051052 | 3.54% | regulation of DNA metabolic process |
| GO:0045444 | 3.54% | fat cell differentiation |
| GO:0060606 | 3.54% | tube closure |
| GO:0060143 | 3.53% | positive regulation of syncytium formation by plasma membrane fusion |
| GO:0035239 | 3.53% | tube morphogenesis |
| GO:0070527 | 3.53% | platelet aggregation |
| GO:0051930 | 3.52% | regulation of sensory perception of pain |
| GO:0048608 | 3.52% | reproductive structure development |
| GO:0034284 | 3.52% | response to monosaccharide |
| GO:0043543 | 3.51% | protein acylation |
| GO:0048589 | 3.51% | developmental growth |
| GO:1903672 | 3.50% | positive regulation of sprouting angiogenesis |
| GO:0070371 | 3.50% | ERK1 and ERK2 cascade |
| GO:0015748 | 3.50% | organophosphate ester transport |
| GO:0007229 | 3.50% | integrin-mediated signaling pathway |
| GO:0006959 | 3.50% | humoral immune response |
| GO:0099537 | 3.50% | trans-synaptic signaling |
| GO:0090183 | 3.50% | regulation of kidney development |
| GO:0051968 | 3.48% | positive regulation of synaptic transmission, glutamatergic |
| GO:0051588 | 3.48% | regulation of neurotransmitter transport |
| GO:1903555 | 3.48% | regulation of tumor necrosis factor superfamily cytokine production |
| GO:0010518 | 3.48% | positive regulation of phospholipase activity |
| GO:1901385 | 3.46% | regulation of voltage-gated calcium channel activity |
| GO:0002763 | 3.45% | positive regulation of myeloid leukocyte differentiation |
| GO:0050708 | 3.45% | regulation of protein secretion |
| GO:0046578 | 3.45% | regulation of Ras protein signal transduction |
| GO:0090174 | 3.45% | organelle membrane fusion |
| GO:0070920 | 3.45% | regulation of production of small RNA involved in gene silencing by RNA |
| GO:0010823 | 3.44% | negative regulation of mitochondrion organization |
| GO:0007413 | 3.44% | axonal fasciculation |
| GO:0071695 | 3.44% | anatomical structure maturation |
| GO:0043248 | 3.44% | proteasome assembly |
| GO:0051262 | 3.44% | protein tetramerization |
| GO:0000079 | 3.43% | regulation of cyclin-dependent protein serine/threonine kinase activity |
| GO:0007187 | 3.43% | G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger |
| GO:0009058 | 3.42% | biosynthetic process |
| GO:0043112 | 3.42% | receptor metabolic process |
| GO:0051054 | 3.41% | positive regulation of DNA metabolic process |
| GO:0014074 | 3.41% | response to purine-containing compound |
| GO:0034109 | 3.41% | homotypic cell-cell adhesion |
| GO:0034103 | 3.41% | regulation of tissue remodeling |
| GO:0007044 | 3.40% | cell-substrate junction assembly |
| GO:0110020 | 3.40% | regulation of actomyosin structure organization |
| GO:0001678 | 3.40% | cellular glucose homeostasis |
| GO:0010977 | 3.40% | negative regulation of neuron projection development |
| GO:0055072 | 3.40% | iron ion homeostasis |
| GO:0060142 | 3.39% | regulation of syncytium formation by plasma membrane fusion |
| GO:0010817 | 3.38% | regulation of hormone levels |
| GO:0060998 | 3.38% | regulation of dendritic spine development |
| GO:1900181 | 3.38% | negative regulation of protein localization to nucleus |
| GO:1901575 | 3.37% | organic substance catabolic process |
| GO:0048741 | 3.37% | skeletal muscle fiber development |
| GO:0051147 | 3.36% | regulation of muscle cell differentiation |
| GO:0106030 | 3.36% | neuron projection fasciculation |
| GO:1903798 | 3.36% | regulation of production of miRNAs involved in gene silencing by miRNA |
| GO:0010712 | 3.36% | regulation of collagen metabolic process |
| GO:0032680 | 3.36% | regulation of tumor necrosis factor production |
| GO:0015850 | 3.34% | organic hydroxy compound transport |
| GO:0034695 | 3.34% | response to prostaglandin E |
| GO:0051251 | 3.34% | positive regulation of lymphocyte activation |
| GO:0046888 | 3.34% | negative regulation of hormone secretion |
| GO:0000902 | 3.33% | cell morphogenesis |
| GO:0008340 | 3.33% | determination of adult lifespan |
| GO:0071260 | 3.33% | cellular response to mechanical stimulus |
| GO:2001252 | 3.33% | positive regulation of chromosome organization |
| GO:0033138 | 3.33% | positive regulation of peptidyl-serine phosphorylation |
| GO:0007189 | 3.32% | adenylate cyclase-activating G protein-coupled receptor signaling pathway |
| GO:0051604 | 3.32% | protein maturation |
| GO:0010470 | 3.32% | regulation of gastrulation |
| GO:0001885 | 3.31% | endothelial cell development |
| GO:0043029 | 3.30% | T cell homeostasis |
| GO:1902622 | 3.30% | regulation of neutrophil migration |
| GO:0043542 | 3.30% | endothelial cell migration |
| GO:0009615 | 3.29% | response to virus |
| GO:1903202 | 3.29% | negative regulation of oxidative stress-induced cell death |
| GO:0010469 | 3.29% | regulation of signaling receptor activity |
| GO:0002250 | 3.28% | adaptive immune response |
| GO:0051495 | 3.28% | positive regulation of cytoskeleton organization |
| GO:0031000 | 3.28% | response to caffeine |
| GO:0042476 | 3.28% | odontogenesis |
| GO:1902624 | 3.27% | positive regulation of neutrophil migration |
| GO:0009749 | 3.27% | response to glucose |
| GO:0080154 | 3.27% | regulation of fertilization |
| GO:0050954 | 3.27% | sensory perception of mechanical stimulus |
| GO:1900408 | 3.26% | negative regulation of cellular response to oxidative stress |
| GO:0006473 | 3.26% | protein acetylation |
| GO:0002715 | 3.26% | regulation of natural killer cell mediated immunity |
| GO:0043009 | 3.25% | chordate embryonic development |
| GO:0045581 | 3.25% | negative regulation of T cell differentiation |
| GO:0010771 | 3.25% | negative regulation of cell morphogenesis involved in differentiation |
| GO:0042771 | 3.24% | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator |
| GO:0051235 | 3.24% | maintenance of location |
| GO:0010951 | 3.24% | negative regulation of endopeptidase activity |
| GO:0009746 | 3.23% | response to hexose |
| GO:0001508 | 3.21% | action potential |
| GO:0090263 | 3.21% | positive regulation of canonical Wnt signaling pathway |
| GO:0007015 | 3.20% | actin filament organization |
| GO:0071479 | 3.20% | cellular response to ionizing radiation |
| GO:0006984 | 3.20% | ER-nucleus signaling pathway |
| GO:0035904 | 3.20% | aorta development |
| GO:0030308 | 3.20% | negative regulation of cell growth |
| GO:0045761 | 3.19% | regulation of adenylate cyclase activity |
| GO:0043406 | 3.19% | positive regulation of MAP kinase activity |
| GO:0032465 | 3.19% | regulation of cytokinesis |
| GO:0006883 | 3.19% | cellular sodium ion homeostasis |
| GO:0022412 | 3.18% | cellular process involved in reproduction in multicellular organism |
| GO:0050982 | 3.18% | detection of mechanical stimulus |
| GO:0048754 | 3.18% | branching morphogenesis of an epithelial tube |
| GO:0060537 | 3.18% | muscle tissue development |
| GO:0048168 | 3.17% | regulation of neuronal synaptic plasticity |
| GO:0021987 | 3.17% | cerebral cortex development |
| GO:0009267 | 3.17% | cellular response to starvation |
| GO:0010608 | 3.16% | posttranscriptional regulation of gene expression |
| GO:0051931 | 3.16% | regulation of sensory perception |
| GO:0018208 | 3.16% | peptidyl-proline modification |
| GO:2000114 | 3.15% | regulation of establishment of cell polarity |
| GO:0045987 | 3.15% | positive regulation of smooth muscle contraction |
| GO:0045980 | 3.15% | negative regulation of nucleotide metabolic process |
| GO:0071385 | 3.15% | cellular response to glucocorticoid stimulus |
| GO:0045787 | 3.14% | positive regulation of cell cycle |
| GO:0140013 | 3.14% | meiotic nuclear division |
| GO:0050808 | 3.14% | synapse organization |
| GO:1901576 | 3.13% | organic substance biosynthetic process |
| GO:0007178 | 3.13% | transmembrane receptor protein serine/threonine kinase signaling pathway |
| GO:0050974 | 3.13% | detection of mechanical stimulus involved in sensory perception |
| GO:2000679 | 3.13% | positive regulation of transcription regulatory region DNA binding |
| GO:0003254 | 3.13% | regulation of membrane depolarization |
| GO:0043467 | 3.12% | regulation of generation of precursor metabolites and energy |
| GO:0071468 | 3.12% | cellular response to acidic pH |
| GO:0045453 | 3.12% | bone resorption |
| GO:1903426 | 3.12% | regulation of reactive oxygen species biosynthetic process |
| GO:0006869 | 3.11% | lipid transport |
| GO:0090303 | 3.11% | positive regulation of wound healing |
| GO:0034644 | 3.10% | cellular response to UV |
| GO:0031397 | 3.10% | negative regulation of protein ubiquitination |
| GO:0031342 | 3.09% | negative regulation of cell killing |
| GO:0046907 | 3.09% | intracellular transport |
| GO:0042269 | 3.09% | regulation of natural killer cell mediated cytotoxicity |
| GO:0006928 | 3.09% | movement of cell or subcellular component |
| GO:0014066 | 3.09% | regulation of phosphatidylinositol 3-kinase signaling |
| GO:0033365 | 3.08% | protein localization to organelle |
| GO:0010830 | 3.08% | regulation of myotube differentiation |
| GO:0006935 | 3.08% | chemotaxis |
| GO:1902235 | 3.08% | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway |
| GO:2000027 | 3.08% | regulation of animal organ morphogenesis |
| GO:0031057 | 3.08% | negative regulation of histone modification |
| GO:0042026 | 3.07% | protein refolding |
| GO:0006661 | 3.07% | phosphatidylinositol biosynthetic process |
| GO:0045620 | 3.07% | negative regulation of lymphocyte differentiation |
| GO:1901380 | 3.06% | negative regulation of potassium ion transmembrane transport |
| GO:0050871 | 3.06% | positive regulation of B cell activation |
| GO:0045582 | 3.06% | positive regulation of T cell differentiation |
| GO:0031669 | 3.06% | cellular response to nutrient levels |
| GO:0042307 | 3.05% | positive regulation of protein import into nucleus |
| GO:0042770 | 3.05% | signal transduction in response to DNA damage |
| GO:1903305 | 3.05% | regulation of regulated secretory pathway |
| GO:0000165 | 3.04% | MAPK cascade |
| GO:0050771 | 3.03% | negative regulation of axonogenesis |
| GO:0045834 | 3.03% | positive regulation of lipid metabolic process |
| GO:2000377 | 3.03% | regulation of reactive oxygen species metabolic process |
| GO:0051640 | 3.03% | organelle localization |
| GO:0070303 | 3.03% | negative regulation of stress-activated protein kinase signaling cascade |
| GO:0031069 | 3.03% | hair follicle morphogenesis |
| GO:0045088 | 3.03% | regulation of innate immune response |
| GO:0045766 | 3.02% | positive regulation of angiogenesis |
| GO:0014015 | 3.02% | positive regulation of gliogenesis |
| GO:1902175 | 3.02% | regulation of oxidative stress-induced intrinsic apoptotic signaling pathway |
| GO:0033555 | 3.02% | multicellular organismal response to stress |
| GO:0036294 | 3.02% | cellular response to decreased oxygen levels |
| GO:1905268 | 3.02% | negative regulation of chromatin organization |
| GO:0061136 | 3.02% | regulation of proteasomal protein catabolic process |
| GO:0002833 | 3.01% | positive regulation of response to biotic stimulus |
| GO:0002822 | 3.01% | regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
| GO:2000117 | 3.01% | negative regulation of cysteine-type endopeptidase activity |
| GO:0010962 | 3.00% | regulation of glucan biosynthetic process |
| GO:0006885 | 3.00% | regulation of pH |
| GO:0010466 | 2.99% | negative regulation of peptidase activity |
| GO:0044249 | 2.99% | cellular biosynthetic process |
| GO:0120163 | 2.99% | negative regulation of cold-induced thermogenesis |
| GO:0071331 | 2.98% | cellular response to hexose stimulus |
| GO:0031060 | 2.98% | regulation of histone methylation |
| GO:1900024 | 2.98% | regulation of substrate adhesion-dependent cell spreading |
| GO:0032890 | 2.98% | regulation of organic acid transport |
| GO:0016485 | 2.98% | protein processing |
| GO:0045577 | 2.97% | regulation of B cell differentiation |
| GO:1903306 | 2.97% | negative regulation of regulated secretory pathway |
| GO:0015914 | 2.96% | phospholipid transport |
| GO:0007029 | 2.96% | endoplasmic reticulum organization |
| GO:0010800 | 2.96% | positive regulation of peptidyl-threonine phosphorylation |
| GO:1901566 | 2.95% | organonitrogen compound biosynthetic process |
| GO:0043506 | 2.95% | regulation of JUN kinase activity |
| GO:0071467 | 2.95% | cellular response to pH |
| GO:0010883 | 2.95% | regulation of lipid storage |
| GO:0090207 | 2.95% | regulation of triglyceride metabolic process |
| GO:0001568 | 2.94% | blood vessel development |
| GO:0051701 | 2.94% | interaction with host |
| GO:0046850 | 2.94% | regulation of bone remodeling |
| GO:0032873 | 2.93% | negative regulation of stress-activated MAPK cascade |
| GO:0034121 | 2.93% | regulation of toll-like receptor signaling pathway |
| GO:0031668 | 2.93% | cellular response to extracellular stimulus |
| GO:0010611 | 2.92% | regulation of cardiac muscle hypertrophy |
| GO:0050900 | 2.92% | leukocyte migration |
| GO:0042177 | 2.91% | negative regulation of protein catabolic process |
| GO:0002708 | 2.91% | positive regulation of lymphocyte mediated immunity |
| GO:0071312 | 2.90% | cellular response to alkaloid |
| GO:0048284 | 2.90% | organelle fusion |
| GO:0007420 | 2.90% | brain development |
| GO:1902106 | 2.90% | negative regulation of leukocyte differentiation |
| GO:0006417 | 2.89% | regulation of translation |
| GO:0071219 | 2.89% | cellular response to molecule of bacterial origin |
| GO:1903708 | 2.88% | positive regulation of hemopoiesis |
| GO:0048747 | 2.88% | muscle fiber development |
| GO:0071326 | 2.88% | cellular response to monosaccharide stimulus |
| GO:2001259 | 2.87% | positive regulation of cation channel activity |
| GO:0090287 | 2.87% | regulation of cellular response to growth factor stimulus |
| GO:0031099 | 2.87% | regeneration |
| GO:0034446 | 2.86% | substrate adhesion-dependent cell spreading |
| GO:0030177 | 2.86% | positive regulation of Wnt signaling pathway |
| GO:2001039 | 2.86% | negative regulation of cellular response to drug |
| GO:0045682 | 2.86% | regulation of epidermis development |
| GO:0071453 | 2.86% | cellular response to oxygen levels |
| GO:0001701 | 2.86% | in utero embryonic development |
| GO:0010811 | 2.85% | positive regulation of cell-substrate adhesion |
| GO:0043627 | 2.85% | response to estrogen |
| GO:0042475 | 2.85% | odontogenesis of dentin-containing tooth |
| GO:0001662 | 2.85% | behavioral fear response |
| GO:0110110 | 2.85% | positive regulation of animal organ morphogenesis |
| GO:0051301 | 2.84% | cell division |
| GO:0034250 | 2.84% | positive regulation of cellular amide metabolic process |
| GO:0071168 | 2.84% | protein localization to chromatin |
| GO:1903557 | 2.84% | positive regulation of tumor necrosis factor superfamily cytokine production |
| GO:1904036 | 2.84% | negative regulation of epithelial cell apoptotic process |
| GO:0022602 | 2.84% | ovulation cycle process |
| GO:0021700 | 2.83% | developmental maturation |
| GO:0071621 | 2.82% | granulocyte chemotaxis |
| GO:0046847 | 2.82% | filopodium assembly |
| GO:0036270 | 2.81% | response to diuretic |
| GO:0071333 | 2.81% | cellular response to glucose stimulus |
| GO:0090304 | 2.81% | nucleic acid metabolic process |
| GO:0099072 | 2.81% | regulation of postsynaptic membrane neurotransmitter receptor levels |
| GO:0050709 | 2.81% | negative regulation of protein secretion |
| GO:0045454 | 2.80% | cell redox homeostasis |
| GO:0034694 | 2.80% | response to prostaglandin |
| GO:1901984 | 2.80% | negative regulation of protein acetylation |
| GO:2000045 | 2.80% | regulation of G1/S transition of mitotic cell cycle |
| GO:2001022 | 2.80% | positive regulation of response to DNA damage stimulus |
| GO:0050921 | 2.79% | positive regulation of chemotaxis |
| GO:0001570 | 2.79% | vasculogenesis |
| GO:0023014 | 2.79% | signal transduction by protein phosphorylation |
| GO:0050729 | 2.79% | positive regulation of inflammatory response |
| GO:0090101 | 2.79% | negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
| GO:0008610 | 2.78% | lipid biosynthetic process |
| GO:0071320 | 2.78% | cellular response to cAMP |
| GO:0031279 | 2.78% | regulation of cyclase activity |
| GO:0002252 | 2.78% | immune effector process |
| GO:0032692 | 2.78% | negative regulation of interleukin-1 production |
| GO:0055001 | 2.77% | muscle cell development |
| GO:0060326 | 2.77% | cell chemotaxis |
| GO:0060191 | 2.77% | regulation of lipase activity |
| GO:0090342 | 2.77% | regulation of cell aging |
| GO:0032733 | 2.76% | positive regulation of interleukin-10 production |
| GO:0090092 | 2.76% | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
| GO:0032760 | 2.75% | positive regulation of tumor necrosis factor production |
| GO:0043624 | 2.75% | cellular protein complex disassembly |
| GO:0032675 | 2.75% | regulation of interleukin-6 production |
| GO:0097327 | 2.75% | response to antineoplastic agent |
| GO:0090090 | 2.74% | negative regulation of canonical Wnt signaling pathway |
| GO:0043372 | 2.74% | positive regulation of CD4-positive, alpha-beta T cell differentiation |
| GO:0043154 | 2.74% | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process |
| GO:0071825 | 2.73% | protein-lipid complex subunit organization |
| GO:0045742 | 2.73% | positive regulation of epidermal growth factor receptor signaling pathway |
| GO:2001021 | 2.73% | negative regulation of response to DNA damage stimulus |
| GO:0030593 | 2.73% | neutrophil chemotaxis |
| GO:0048864 | 2.73% | stem cell development |
| GO:0071230 | 2.73% | cellular response to amino acid stimulus |
| GO:0140056 | 2.72% | organelle localization by membrane tethering |
| GO:0035335 | 2.72% | peptidyl-tyrosine dephosphorylation |
| GO:0071103 | 2.70% | DNA conformation change |
| GO:0045920 | 2.70% | negative regulation of exocytosis |
| GO:0090276 | 2.70% | regulation of peptide hormone secretion |
| GO:1904589 | 2.70% | regulation of protein import |
| GO:0006396 | 2.70% | RNA processing |
| GO:1900274 | 2.70% | regulation of phospholipase C activity |
| GO:0045672 | 2.70% | positive regulation of osteoclast differentiation |
| GO:0010831 | 2.69% | positive regulation of myotube differentiation |
| GO:0042330 | 2.68% | taxis |
| GO:0071456 | 2.68% | cellular response to hypoxia |
| GO:0002209 | 2.68% | behavioral defense response |
| GO:0014743 | 2.68% | regulation of muscle hypertrophy |
| GO:0009798 | 2.68% | axis specification |
| GO:0090278 | 2.67% | negative regulation of peptide hormone secretion |
| GO:0060969 | 2.67% | negative regulation of gene silencing |
| GO:0051149 | 2.67% | positive regulation of muscle cell differentiation |
| GO:0071222 | 2.67% | cellular response to lipopolysaccharide |
| GO:0044060 | 2.66% | regulation of endocrine process |
| GO:0051057 | 2.66% | positive regulation of small GTPase mediated signal transduction |
| GO:0060078 | 2.66% | regulation of postsynaptic membrane potential |
| GO:0001658 | 2.66% | branching involved in ureteric bud morphogenesis |
| GO:0010803 | 2.66% | regulation of tumor necrosis factor-mediated signaling pathway |
| GO:0042306 | 2.66% | regulation of protein import into nucleus |
| GO:1905897 | 2.65% | regulation of response to endoplasmic reticulum stress |
| GO:0120031 | 2.65% | plasma membrane bounded cell projection assembly |
| GO:0016070 | 2.65% | RNA metabolic process |
| GO:0030239 | 2.64% | myofibril assembly |
| GO:0045104 | 2.64% | intermediate filament cytoskeleton organization |
| GO:0046716 | 2.64% | muscle cell cellular homeostasis |
| GO:0007605 | 2.64% | sensory perception of sound |
| GO:0008347 | 2.64% | glial cell migration |
| GO:0110111 | 2.64% | negative regulation of animal organ morphogenesis |
| GO:0035821 | 2.63% | modification of morphology or physiology of other organism |
| GO:0007190 | 2.63% | activation of adenylate cyclase activity |
| GO:0006026 | 2.62% | aminoglycan catabolic process |
| GO:2000378 | 2.61% | negative regulation of reactive oxygen species metabolic process |
| GO:0030879 | 2.61% | mammary gland development |
| GO:0072332 | 2.61% | intrinsic apoptotic signaling pathway by p53 class mediator |
| GO:0010332 | 2.61% | response to gamma radiation |
| GO:0002886 | 2.61% | regulation of myeloid leukocyte mediated immunity |
| GO:0031062 | 2.61% | positive regulation of histone methylation |
| GO:0030330 | 2.61% | DNA damage response, signal transduction by p53 class mediator |
| GO:0050995 | 2.61% | negative regulation of lipid catabolic process |
| GO:0002064 | 2.60% | epithelial cell development |
| GO:0071677 | 2.60% | positive regulation of mononuclear cell migration |
| GO:0030217 | 2.59% | T cell differentiation |
| GO:0098801 | 2.59% | regulation of renal system process |
| GO:0019233 | 2.59% | sensory perception of pain |
| GO:0050906 | 2.59% | detection of stimulus involved in sensory perception |
| GO:0048536 | 2.59% | spleen development |
| GO:0051155 | 2.58% | positive regulation of striated muscle cell differentiation |
| GO:0048638 | 2.58% | regulation of developmental growth |
| GO:0046488 | 2.58% | phosphatidylinositol metabolic process |
| GO:0034333 | 2.58% | adherens junction assembly |
| GO:0030097 | 2.57% | hemopoiesis |
| GO:0032886 | 2.57% | regulation of microtubule-based process |
| GO:1901186 | 2.57% | positive regulation of ERBB signaling pathway |
| GO:0040036 | 2.57% | regulation of fibroblast growth factor receptor signaling pathway |
| GO:0044403 | 2.56% | symbiotic process |
| GO:0070873 | 2.56% | regulation of glycogen metabolic process |
| GO:0032940 | 2.56% | secretion by cell |
| GO:0006865 | 2.56% | amino acid transport |
| GO:0097192 | 2.55% | extrinsic apoptotic signaling pathway in absence of ligand |
| GO:0045736 | 2.55% | negative regulation of cyclin-dependent protein serine/threonine kinase activity |
| GO:1901021 | 2.55% | positive regulation of calcium ion transmembrane transporter activity |
| GO:0032691 | 2.55% | negative regulation of interleukin-1 beta production |
| GO:0045589 | 2.54% | regulation of regulatory T cell differentiation |
| GO:0009620 | 2.54% | response to fungus |
| GO:0045661 | 2.54% | regulation of myoblast differentiation |
| GO:0006886 | 2.54% | intracellular protein transport |
| GO:0042113 | 2.53% | B cell activation |
| GO:0006836 | 2.53% | neurotransmitter transport |
| GO:0050870 | 2.53% | positive regulation of T cell activation |
| GO:0030595 | 2.53% | leukocyte chemotaxis |
| GO:0016071 | 2.53% | mRNA metabolic process |
| GO:0043244 | 2.53% | regulation of protein complex disassembly |
| GO:0051339 | 2.53% | regulation of lyase activity |
| GO:0030031 | 2.53% | cell projection assembly |
| GO:0045685 | 2.53% | regulation of glial cell differentiation |
| GO:0071384 | 2.51% | cellular response to corticosteroid stimulus |
| GO:0046579 | 2.51% | positive regulation of Ras protein signal transduction |
| GO:0042634 | 2.50% | regulation of hair cycle |
| GO:0034104 | 2.50% | negative regulation of tissue remodeling |
| GO:0044419 | 2.50% | interspecies interaction between organisms |
| GO:0001558 | 2.50% | regulation of cell growth |
| GO:0032892 | 2.50% | positive regulation of organic acid transport |
| GO:0007017 | 2.49% | microtubule-based process |
| GO:0090312 | 2.49% | positive regulation of protein deacetylation |
| GO:0032878 | 2.49% | regulation of establishment or maintenance of cell polarity |
| GO:0048660 | 2.49% | regulation of smooth muscle cell proliferation |
| GO:0050994 | 2.48% | regulation of lipid catabolic process |
| GO:1901998 | 2.48% | toxin transport |
| GO:1903671 | 2.48% | negative regulation of sprouting angiogenesis |
| GO:2000757 | 2.48% | negative regulation of peptidyl-lysine acetylation |
| GO:0031061 | 2.48% | negative regulation of histone methylation |
| GO:1903579 | 2.48% | negative regulation of ATP metabolic process |
| GO:0015672 | 2.48% | monovalent inorganic cation transport |
| GO:0032026 | 2.48% | response to magnesium ion |
| GO:1990830 | 2.47% | cellular response to leukemia inhibitory factor |
| GO:0009057 | 2.47% | macromolecule catabolic process |
| GO:0032943 | 2.47% | mononuclear cell proliferation |
| GO:0030866 | 2.47% | cortical actin cytoskeleton organization |
| GO:0071482 | 2.47% | cellular response to light stimulus |
| GO:0062149 | 2.47% | detection of stimulus involved in sensory perception of pain |
| GO:1903727 | 2.47% | positive regulation of phospholipid metabolic process |
| GO:1990823 | 2.46% | response to leukemia inhibitory factor |
| GO:0002790 | 2.46% | peptide secretion |
| GO:0045124 | 2.45% | regulation of bone resorption |
| GO:0016032 | 2.45% | viral process |
| GO:0010888 | 2.44% | negative regulation of lipid storage |
| GO:0034698 | 2.44% | response to gonadotropin |
| GO:0043388 | 2.44% | positive regulation of DNA binding |
| GO:0008038 | 2.44% | neuron recognition |
| GO:0017158 | 2.44% | regulation of calcium ion-dependent exocytosis |
| GO:0045109 | 2.44% | intermediate filament organization |
| GO:0023061 | 2.44% | signal release |
| GO:1905523 | 2.44% | positive regulation of macrophage migration |
| GO:0006970 | 2.44% | response to osmotic stress |
| GO:1903046 | 2.43% | meiotic cell cycle process |
| GO:2001237 | 2.43% | negative regulation of extrinsic apoptotic signaling pathway |
| GO:0014068 | 2.42% | positive regulation of phosphatidylinositol 3-kinase signaling |
| GO:0042596 | 2.42% | fear response |
| GO:0009886 | 2.42% | post-embryonic animal morphogenesis |
| GO:0033209 | 2.41% | tumor necrosis factor-mediated signaling pathway |
| GO:0048311 | 2.41% | mitochondrion distribution |
| GO:1903053 | 2.41% | regulation of extracellular matrix organization |
| GO:0010939 | 2.41% | regulation of necrotic cell death |
| GO:0051961 | 2.40% | negative regulation of nervous system development |
| GO:0085029 | 2.40% | extracellular matrix assembly |
| GO:0031424 | 2.40% | keratinization |
| GO:0038034 | 2.40% | signal transduction in absence of ligand |
| GO:0071371 | 2.39% | cellular response to gonadotropin stimulus |
| GO:0032781 | 2.39% | positive regulation of ATPase activity |
| GO:0046640 | 2.38% | regulation of alpha-beta T cell proliferation |
| GO:2001238 | 2.38% | positive regulation of extrinsic apoptotic signaling pathway |
| GO:0032653 | 2.38% | regulation of interleukin-10 production |
| GO:0050775 | 2.38% | positive regulation of dendrite morphogenesis |
| GO:0007588 | 2.37% | excretion |
| GO:0002824 | 2.36% | positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
| GO:0046628 | 2.36% | positive regulation of insulin receptor signaling pathway |
| GO:0090184 | 2.36% | positive regulation of kidney development |
| GO:0006487 | 2.35% | protein N-linked glycosylation |
| GO:1904752 | 2.35% | regulation of vascular associated smooth muscle cell migration |
| GO:1904591 | 2.35% | positive regulation of protein import |
| GO:0150077 | 2.35% | regulation of neuroinflammatory response |
| GO:0046823 | 2.35% | negative regulation of nucleocytoplasmic transport |
| GO:2000516 | 2.35% | positive regulation of CD4-positive, alpha-beta T cell activation |
| GO:0002269 | 2.34% | leukocyte activation involved in inflammatory response |
| GO:0007179 | 2.34% | transforming growth factor beta receptor signaling pathway |
| GO:0045103 | 2.34% | intermediate filament-based process |
| GO:0016197 | 2.34% | endosomal transport |
| GO:0045087 | 2.34% | innate immune response |
| GO:0006027 | 2.33% | glycosaminoglycan catabolic process |
| GO:0006857 | 2.33% | oligopeptide transport |
| GO:0032673 | 2.32% | regulation of interleukin-4 production |
| GO:0000904 | 2.32% | cell morphogenesis involved in differentiation |
| GO:0043010 | 2.32% | camera-type eye development |
| GO:0045922 | 2.32% | negative regulation of fatty acid metabolic process |
| GO:0050920 | 2.32% | regulation of chemotaxis |
| GO:0003014 | 2.31% | renal system process |
| GO:0010594 | 2.31% | regulation of endothelial cell migration |
| GO:0051402 | 2.31% | neuron apoptotic process |
| GO:0019730 | 2.31% | antimicrobial humoral response |
| GO:0002026 | 2.31% | regulation of the force of heart contraction |
| GO:0016358 | 2.31% | dendrite development |
| GO:0097164 | 2.31% | ammonium ion metabolic process |
| GO:0032965 | 2.30% | regulation of collagen biosynthetic process |
| GO:0055092 | 2.30% | sterol homeostasis |
| GO:0032228 | 2.30% | regulation of synaptic transmission, GABAergic |
| GO:0002090 | 2.30% | regulation of receptor internalization |
| GO:0043588 | 2.30% | skin development |
| GO:0032008 | 2.30% | positive regulation of TOR signaling |
| GO:0048643 | 2.30% | positive regulation of skeletal muscle tissue development |
| GO:0002724 | 2.30% | regulation of T cell cytokine production |
| GO:1902116 | 2.30% | negative regulation of organelle assembly |
| GO:0045599 | 2.29% | negative regulation of fat cell differentiation |
| GO:0140352 | 2.29% | export from cell |
| GO:0035637 | 2.29% | multicellular organismal signaling |
| GO:0014823 | 2.29% | response to activity |
| GO:0014706 | 2.29% | striated muscle tissue development |
| GO:0048015 | 2.29% | phosphatidylinositol-mediated signaling |
| GO:0098926 | 2.29% | postsynaptic signal transduction |
| GO:0051154 | 2.28% | negative regulation of striated muscle cell differentiation |
| GO:0090208 | 2.28% | positive regulation of triglyceride metabolic process |
| GO:0051310 | 2.28% | metaphase plate congression |
| GO:0050820 | 2.28% | positive regulation of coagulation |
| GO:0060149 | 2.28% | negative regulation of posttranscriptional gene silencing |
| GO:0030194 | 2.28% | positive regulation of blood coagulation |
| GO:0008277 | 2.27% | regulation of G protein-coupled receptor signaling pathway |
| GO:0014742 | 2.27% | positive regulation of muscle hypertrophy |
| GO:0046676 | 2.27% | negative regulation of insulin secretion |
| GO:0071709 | 2.27% | membrane assembly |
| GO:0070328 | 2.27% | triglyceride homeostasis |
| GO:0022600 | 2.26% | digestive system process |
| GO:0051276 | 2.26% | chromosome organization |
| GO:1900744 | 2.26% | regulation of p38MAPK cascade |
| GO:0001656 | 2.26% | metanephros development |
| GO:0002526 | 2.26% | acute inflammatory response |
| GO:0044281 | 2.25% | small molecule metabolic process |
| GO:0007219 | 2.25% | Notch signaling pathway |
| GO:0045621 | 2.25% | positive regulation of lymphocyte differentiation |
| GO:0060840 | 2.25% | artery development |
| GO:0048259 | 2.24% | regulation of receptor-mediated endocytosis |
| GO:0070665 | 2.24% | positive regulation of leukocyte proliferation |
| GO:1900026 | 2.24% | positive regulation of substrate adhesion-dependent cell spreading |
| GO:0060359 | 2.23% | response to ammonium ion |
| GO:0007193 | 2.23% | adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway |
| GO:0048103 | 2.23% | somatic stem cell division |
| GO:1900006 | 2.23% | positive regulation of dendrite development |
| GO:0019218 | 2.22% | regulation of steroid metabolic process |
| GO:0045912 | 2.22% | negative regulation of carbohydrate metabolic process |
| GO:0006665 | 2.22% | sphingolipid metabolic process |
| GO:0060967 | 2.22% | negative regulation of gene silencing by RNA |
| GO:0050905 | 2.22% | neuromuscular process |
| GO:0050768 | 2.22% | negative regulation of neurogenesis |
| GO:0048871 | 2.21% | multicellular organismal homeostasis |
| GO:0002637 | 2.21% | regulation of immunoglobulin production |
| GO:0032891 | 2.21% | negative regulation of organic acid transport |
| GO:0090049 | 2.20% | regulation of cell migration involved in sprouting angiogenesis |
| GO:0010517 | 2.20% | regulation of phospholipase activity |
| GO:0007205 | 2.20% | protein kinase C-activating G protein-coupled receptor signaling pathway |
| GO:0044282 | 2.20% | small molecule catabolic process |
| GO:1903214 | 2.20% | regulation of protein targeting to mitochondrion |
| GO:0001912 | 2.19% | positive regulation of leukocyte mediated cytotoxicity |
| GO:0002888 | 2.19% | positive regulation of myeloid leukocyte mediated immunity |
| GO:0007269 | 2.19% | neurotransmitter secretion |
| GO:0002922 | 2.17% | positive regulation of humoral immune response |
| GO:1901185 | 2.17% | negative regulation of ERBB signaling pathway |
| GO:2001251 | 2.16% | negative regulation of chromosome organization |
| GO:0061077 | 2.16% | chaperone-mediated protein folding |
| GO:0010631 | 2.15% | epithelial cell migration |
| GO:0048731 | 2.15% | system development |
| GO:0033077 | 2.15% | T cell differentiation in thymus |
| GO:1900048 | 2.15% | positive regulation of hemostasis |
| GO:0002764 | 2.15% | immune response-regulating signaling pathway |
| GO:0097120 | 2.14% | receptor localization to synapse |
| GO:0050829 | 2.14% | defense response to Gram-negative bacterium |
| GO:0055078 | 2.14% | sodium ion homeostasis |
| GO:0006582 | 2.14% | melanin metabolic process |
| GO:0001822 | 2.14% | kidney development |
| GO:0045165 | 2.14% | cell fate commitment |
| GO:0098754 | 2.14% | detoxification |
| GO:2000273 | 2.14% | positive regulation of signaling receptor activity |
| GO:0009644 | 2.14% | response to high light intensity |
| GO:0033688 | 2.13% | regulation of osteoblast proliferation |
| GO:0002711 | 2.13% | positive regulation of T cell mediated immunity |
| GO:0010632 | 2.13% | regulation of epithelial cell migration |
| GO:0007612 | 2.13% | learning |
| GO:0002757 | 2.13% | immune response-activating signal transduction |
| GO:0002686 | 2.13% | negative regulation of leukocyte migration |
| GO:0009306 | 2.12% | protein secretion |
| GO:0090100 | 2.12% | positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
| GO:0006091 | 2.12% | generation of precursor metabolites and energy |
| GO:2000401 | 2.12% | regulation of lymphocyte migration |
| GO:2000310 | 2.12% | regulation of NMDA receptor activity |
| GO:0007214 | 2.11% | gamma-aminobutyric acid signaling pathway |
| GO:0051955 | 2.10% | regulation of amino acid transport |
| GO:0034620 | 2.10% | cellular response to unfolded protein |
| GO:1990928 | 2.10% | response to amino acid starvation |
| GO:0043300 | 2.10% | regulation of leukocyte degranulation |
| GO:0042304 | 2.10% | regulation of fatty acid biosynthetic process |
| GO:0046651 | 2.10% | lymphocyte proliferation |
| GO:0034198 | 2.10% | cellular response to amino acid starvation |
| GO:0030509 | 2.09% | BMP signaling pathway |
| GO:1902019 | 2.09% | regulation of cilium-dependent cell motility |
| GO:0046683 | 2.09% | response to organophosphorus |
| GO:0042423 | 2.09% | catecholamine biosynthetic process |
| GO:0061900 | 2.09% | glial cell activation |
| GO:0034332 | 2.09% | adherens junction organization |
| GO:0010467 | 2.09% | gene expression |
| GO:1902904 | 2.09% | negative regulation of supramolecular fiber organization |
| GO:0033233 | 2.08% | regulation of protein sumoylation |
| GO:0035025 | 2.08% | positive regulation of Rho protein signal transduction |
| GO:0048017 | 2.08% | inositol lipid-mediated signaling |
| GO:0006913 | 2.08% | nucleocytoplasmic transport |
| GO:2001222 | 2.08% | regulation of neuron migration |
| GO:0002768 | 2.08% | immune response-regulating cell surface receptor signaling pathway |
| GO:0006953 | 2.07% | acute-phase response |
| GO:0016042 | 2.07% | lipid catabolic process |
| GO:0006914 | 2.07% | autophagy |
| GO:0001778 | 2.07% | plasma membrane repair |
| GO:0032354 | 2.07% | response to follicle-stimulating hormone |
| GO:0006658 | 2.06% | phosphatidylserine metabolic process |
| GO:0051571 | 2.06% | positive regulation of histone H3-K4 methylation |
| GO:0043901 | 2.06% | negative regulation of multi-organism process |
| GO:0006888 | 2.06% | endoplasmic reticulum to Golgi vesicle-mediated transport |
| GO:0043407 | 2.06% | negative regulation of MAP kinase activity |
| GO:0002244 | 2.06% | hematopoietic progenitor cell differentiation |
| GO:0043516 | 2.06% | regulation of DNA damage response, signal transduction by p53 class mediator |
| GO:0006820 | 2.05% | anion transport |
| GO:0061919 | 2.05% | process utilizing autophagic mechanism |
| GO:0031338 | 2.05% | regulation of vesicle fusion |
| GO:0031579 | 2.05% | membrane raft organization |
| GO:0014065 | 2.05% | phosphatidylinositol 3-kinase signaling |
| GO:1902692 | 2.05% | regulation of neuroblast proliferation |
| GO:0002792 | 2.05% | negative regulation of peptide secretion |
| GO:0007212 | 2.05% | dopamine receptor signaling pathway |
| GO:0010613 | 2.04% | positive regulation of cardiac muscle hypertrophy |
| GO:0090322 | 2.04% | regulation of superoxide metabolic process |
| GO:0042116 | 2.04% | macrophage activation |
| GO:0030104 | 2.04% | water homeostasis |
| GO:0002521 | 2.04% | leukocyte differentiation |
| GO:1900101 | 2.04% | regulation of endoplasmic reticulum unfolded protein response |
| GO:0033003 | 2.04% | regulation of mast cell activation |
| GO:2000272 | 2.04% | negative regulation of signaling receptor activity |
| GO:0071402 | 2.04% | cellular response to lipoprotein particle stimulus |
| GO:1901381 | 2.03% | positive regulation of potassium ion transmembrane transport |
| GO:0048469 | 2.03% | cell maturation |
| GO:1902932 | 2.03% | positive regulation of alcohol biosynthetic process |
| GO:1903556 | 2.03% | negative regulation of tumor necrosis factor superfamily cytokine production |
| GO:0043620 | 2.03% | regulation of DNA-templated transcription in response to stress |
| GO:0051169 | 2.03% | nuclear transport |
| GO:0032434 | 2.03% | regulation of proteasomal ubiquitin-dependent protein catabolic process |
| GO:0032148 | 2.03% | activation of protein kinase B activity |
| GO:0002639 | 2.02% | positive regulation of immunoglobulin production |
| GO:0048634 | 2.02% | regulation of muscle organ development |
| GO:1990266 | 2.02% | neutrophil migration |
| GO:0055114 | 2.02% | oxidation-reduction process |
| GO:2000311 | 2.02% | regulation of AMPA receptor activity |
| GO:0016572 | 2.02% | histone phosphorylation |
| GO:0002832 | 2.01% | negative regulation of response to biotic stimulus |
| GO:0030183 | 2.01% | B cell differentiation |
| GO:2000242 | 2.00% | negative regulation of reproductive process |
| GO:0055094 | 2.00% | response to lipoprotein particle |
| GO:0051965 | 2.00% | positive regulation of synapse assembly |
| GO:0051957 | 2.00% | positive regulation of amino acid transport |
| GO:2000058 | 1.99% | regulation of ubiquitin-dependent protein catabolic process |
| GO:0045214 | 1.99% | sarcomere organization |
| GO:0016202 | 1.99% | regulation of striated muscle tissue development |
| GO:0021795 | 1.99% | cerebral cortex cell migration |
| GO:0006356 | 1.99% | regulation of transcription by RNA polymerase I |
| GO:0030098 | 1.99% | lymphocyte differentiation |
| GO:0044782 | 1.98% | cilium organization |
| GO:1902229 | 1.98% | regulation of intrinsic apoptotic signaling pathway in response to DNA damage |
| GO:0032271 | 1.98% | regulation of protein polymerization |
| GO:0032652 | 1.98% | regulation of interleukin-1 production |
| GO:0032715 | 1.97% | negative regulation of interleukin-6 production |
| GO:0006641 | 1.97% | triglyceride metabolic process |
| GO:0048169 | 1.97% | regulation of long-term neuronal synaptic plasticity |
| GO:0045639 | 1.97% | positive regulation of myeloid cell differentiation |
| GO:2000514 | 1.97% | regulation of CD4-positive, alpha-beta T cell activation |
| GO:1902749 | 1.97% | regulation of cell cycle G2/M phase transition |
| GO:0001843 | 1.97% | neural tube closure |
| GO:0060071 | 1.97% | Wnt signaling pathway, planar cell polarity pathway |
| GO:0002720 | 1.97% | positive regulation of cytokine production involved in immune response |
| GO:2000352 | 1.97% | negative regulation of endothelial cell apoptotic process |
| GO:0043647 | 1.97% | inositol phosphate metabolic process |
| GO:0010837 | 1.96% | regulation of keratinocyte proliferation |
| GO:1901617 | 1.96% | organic hydroxy compound biosynthetic process |
| GO:0002274 | 1.96% | myeloid leukocyte activation |
| GO:0042742 | 1.96% | defense response to bacterium |
| GO:0035967 | 1.95% | cellular response to topologically incorrect protein |
| GO:1900015 | 1.95% | regulation of cytokine production involved in inflammatory response |
| GO:0001505 | 1.95% | regulation of neurotransmitter levels |
| GO:0098693 | 1.95% | regulation of synaptic vesicle cycle |
| GO:0043903 | 1.95% | regulation of symbiosis, encompassing mutualism through parasitism |
| GO:0035902 | 1.95% | response to immobilization stress |
| GO:0070997 | 1.95% | neuron death |
| GO:0016311 | 1.94% | dephosphorylation |
| GO:0060271 | 1.94% | cilium assembly |
| GO:0001774 | 1.94% | microglial cell activation |
| GO:1904705 | 1.94% | regulation of vascular smooth muscle cell proliferation |
| GO:0010721 | 1.94% | negative regulation of cell development |
| GO:0045428 | 1.93% | regulation of nitric oxide biosynthetic process |
| GO:0060688 | 1.93% | regulation of morphogenesis of a branching structure |
| GO:0042632 | 1.93% | cholesterol homeostasis |
| GO:0097530 | 1.93% | granulocyte migration |
| GO:0019752 | 1.93% | carboxylic acid metabolic process |
| GO:0032928 | 1.92% | regulation of superoxide anion generation |
| GO:0055093 | 1.92% | response to hyperoxia |
| GO:0016239 | 1.92% | positive regulation of macroautophagy |
| GO:0045058 | 1.92% | T cell selection |
| GO:1903831 | 1.92% | signal transduction involved in cellular response to ammonium ion |
| GO:0015711 | 1.92% | organic anion transport |
| GO:0035966 | 1.91% | response to topologically incorrect protein |
| GO:0022612 | 1.91% | gland morphogenesis |
| GO:0070507 | 1.91% | regulation of microtubule cytoskeleton organization |
| GO:0097529 | 1.91% | myeloid leukocyte migration |
| GO:0046467 | 1.91% | membrane lipid biosynthetic process |
| GO:0032197 | 1.91% | transposition, RNA-mediated |
| GO:0051591 | 1.91% | response to cAMP |
| GO:0009791 | 1.91% | post-embryonic development |
| GO:0051216 | 1.90% | cartilage development |
| GO:1903792 | 1.90% | negative regulation of anion transport |
| GO:0036296 | 1.90% | response to increased oxygen levels |
| GO:0045981 | 1.90% | positive regulation of nucleotide metabolic process |
| GO:2000463 | 1.90% | positive regulation of excitatory postsynaptic potential |
| GO:0009110 | 1.90% | vitamin biosynthetic process |
| GO:0003007 | 1.90% | heart morphogenesis |
| GO:1903421 | 1.89% | regulation of synaptic vesicle recycling |
| GO:0060759 | 1.89% | regulation of response to cytokine stimulus |
| GO:0048193 | 1.89% | Golgi vesicle transport |
| GO:0072091 | 1.89% | regulation of stem cell proliferation |
| GO:0055002 | 1.88% | striated muscle cell development |
| GO:0001654 | 1.88% | eye development |
| GO:2001243 | 1.88% | negative regulation of intrinsic apoptotic signaling pathway |
| GO:0048568 | 1.88% | embryonic organ development |
| GO:0035592 | 1.88% | establishment of protein localization to extracellular region |
| GO:0061001 | 1.87% | regulation of dendritic spine morphogenesis |
| GO:2000379 | 1.87% | positive regulation of reactive oxygen species metabolic process |
| GO:0051303 | 1.87% | establishment of chromosome localization |
| GO:0060706 | 1.87% | cell differentiation involved in embryonic placenta development |
| GO:0090200 | 1.87% | positive regulation of release of cytochrome c from mitochondria |
| GO:0019827 | 1.87% | stem cell population maintenance |
| GO:1900544 | 1.86% | positive regulation of purine nucleotide metabolic process |
| GO:1900078 | 1.86% | positive regulation of cellular response to insulin stimulus |
| GO:0006941 | 1.86% | striated muscle contraction |
| GO:0120161 | 1.86% | regulation of cold-induced thermogenesis |
| GO:0042104 | 1.86% | positive regulation of activated T cell proliferation |
| GO:0048563 | 1.86% | post-embryonic animal organ morphogenesis |
| GO:0033561 | 1.86% | regulation of water loss via skin |
| GO:1904893 | 1.86% | negative regulation of receptor signaling pathway via STAT |
| GO:0055090 | 1.86% | acylglycerol homeostasis |
| GO:0060632 | 1.86% | regulation of microtubule-based movement |
| GO:0032946 | 1.85% | positive regulation of mononuclear cell proliferation |
| GO:1902473 | 1.85% | regulation of protein localization to synapse |
| GO:0006890 | 1.85% | retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum |
| GO:0043457 | 1.85% | regulation of cellular respiration |
| GO:0003015 | 1.85% | heart process |
| GO:0009395 | 1.85% | phospholipid catabolic process |
| GO:0002758 | 1.84% | innate immune response-activating signal transduction |
| GO:0061515 | 1.84% | myeloid cell development |
| GO:0010743 | 1.84% | regulation of macrophage derived foam cell differentiation |
| GO:0006643 | 1.84% | membrane lipid metabolic process |
| GO:0095500 | 1.84% | acetylcholine receptor signaling pathway |
| GO:0065005 | 1.83% | protein-lipid complex assembly |
| GO:0045833 | 1.83% | negative regulation of lipid metabolic process |
| GO:0003009 | 1.83% | skeletal muscle contraction |
| GO:0032720 | 1.82% | negative regulation of tumor necrosis factor production |
| GO:0045598 | 1.82% | regulation of fat cell differentiation |
| GO:0090175 | 1.82% | regulation of establishment of planar polarity |
| GO:0045638 | 1.82% | negative regulation of myeloid cell differentiation |
| GO:0015931 | 1.82% | nucleobase-containing compound transport |
| GO:0006893 | 1.82% | Golgi to plasma membrane transport |
| GO:0050999 | 1.82% | regulation of nitric-oxide synthase activity |
| GO:0010714 | 1.82% | positive regulation of collagen metabolic process |
| GO:0010927 | 1.81% | cellular component assembly involved in morphogenesis |
| GO:0030947 | 1.81% | regulation of vascular endothelial growth factor receptor signaling pathway |
| GO:0015844 | 1.81% | monoamine transport |
| GO:0051150 | 1.81% | regulation of smooth muscle cell differentiation |
| GO:0031098 | 1.81% | stress-activated protein kinase signaling cascade |
| GO:0010259 | 1.81% | multicellular organism aging |
| GO:0007286 | 1.81% | spermatid development |
| GO:0014075 | 1.81% | response to amine |
| GO:0010001 | 1.81% | glial cell differentiation |
| GO:0051053 | 1.80% | negative regulation of DNA metabolic process |
| GO:1902893 | 1.80% | regulation of pri-miRNA transcription by RNA polymerase II |
| GO:0043414 | 1.80% | macromolecule methylation |
| GO:0071675 | 1.80% | regulation of mononuclear cell migration |
| GO:0060079 | 1.79% | excitatory postsynaptic potential |
| GO:0071692 | 1.79% | protein localization to extracellular region |
| GO:0007602 | 1.79% | phototransduction |
| GO:0051236 | 1.79% | establishment of RNA localization |
| GO:1902414 | 1.79% | protein localization to cell junction |
| GO:0050796 | 1.79% | regulation of insulin secretion |
| GO:1903363 | 1.78% | negative regulation of cellular protein catabolic process |
| GO:0032990 | 1.78% | cell part morphogenesis |
| GO:1904019 | 1.78% | epithelial cell apoptotic process |
| GO:0006413 | 1.78% | translational initiation |
| GO:0002719 | 1.77% | negative regulation of cytokine production involved in immune response |
| GO:0044283 | 1.77% | small molecule biosynthetic process |
| GO:0001756 | 1.77% | somitogenesis |
| GO:0042462 | 1.77% | eye photoreceptor cell development |
| GO:0001657 | 1.77% | ureteric bud development |
| GO:0045844 | 1.77% | positive regulation of striated muscle tissue development |
| GO:0035282 | 1.76% | segmentation |
| GO:0099643 | 1.76% | signal release from synapse |
| GO:0061005 | 1.76% | cell differentiation involved in kidney development |
| GO:0043507 | 1.76% | positive regulation of JUN kinase activity |
| GO:0090596 | 1.75% | sensory organ morphogenesis |
| GO:0021885 | 1.75% | forebrain cell migration |
| GO:0043618 | 1.75% | regulation of transcription from RNA polymerase II promoter in response to stress |
| GO:1902993 | 1.75% | positive regulation of amyloid precursor protein catabolic process |
| GO:0050657 | 1.74% | nucleic acid transport |
| GO:0071772 | 1.74% | response to BMP |
| GO:0002429 | 1.74% | immune response-activating cell surface receptor signaling pathway |
| GO:0034645 | 1.74% | cellular macromolecule biosynthetic process |
| GO:0006470 | 1.74% | protein dephosphorylation |
| GO:0001975 | 1.74% | response to amphetamine |
| GO:0071480 | 1.73% | cellular response to gamma radiation |
| GO:0008643 | 1.73% | carbohydrate transport |
| GO:0072676 | 1.73% | lymphocyte migration |
| GO:0045669 | 1.73% | positive regulation of osteoblast differentiation |
| GO:0035295 | 1.73% | tube development |
| GO:0007623 | 1.73% | circadian rhythm |
| GO:0014031 | 1.73% | mesenchymal cell development |
| GO:0010661 | 1.73% | positive regulation of muscle cell apoptotic process |
| GO:0001562 | 1.73% | response to protozoan |
| GO:0051650 | 1.72% | establishment of vesicle localization |
| GO:0001569 | 1.72% | branching involved in blood vessel morphogenesis |
| GO:0010862 | 1.72% | positive regulation of pathway-restricted SMAD protein phosphorylation |
| GO:0031640 | 1.72% | killing of cells of other organism |
| GO:0002726 | 1.72% | positive regulation of T cell cytokine production |
| GO:0050658 | 1.72% | RNA transport |
| GO:0007034 | 1.72% | vacuolar transport |
| GO:0031109 | 1.72% | microtubule polymerization or depolymerization |
| GO:0007614 | 1.71% | short-term memory |
| GO:2000243 | 1.71% | positive regulation of reproductive process |
| GO:0060560 | 1.71% | developmental growth involved in morphogenesis |
| GO:0045927 | 1.71% | positive regulation of growth |
| GO:0050766 | 1.71% | positive regulation of phagocytosis |
| GO:0044764 | 1.70% | multi-organism cellular process |
| GO:0060122 | 1.70% | inner ear receptor cell stereocilium organization |
| GO:0009713 | 1.70% | catechol-containing compound biosynthetic process |
| GO:0034123 | 1.70% | positive regulation of toll-like receptor signaling pathway |
| GO:0030728 | 1.70% | ovulation |
| GO:0060348 | 1.70% | bone development |
| GO:0010884 | 1.70% | positive regulation of lipid storage |
| GO:0030833 | 1.70% | regulation of actin filament polymerization |
| GO:0098727 | 1.70% | maintenance of cell number |
| GO:0045824 | 1.70% | negative regulation of innate immune response |
| GO:0045663 | 1.70% | positive regulation of myoblast differentiation |
| GO:0043413 | 1.70% | macromolecule glycosylation |
| GO:2000404 | 1.69% | regulation of T cell migration |
| GO:2000191 | 1.69% | regulation of fatty acid transport |
| GO:0010042 | 1.69% | response to manganese ion |
| GO:1902074 | 1.69% | response to salt |
| GO:0006304 | 1.69% | DNA modification |
| GO:0045089 | 1.69% | positive regulation of innate immune response |
| GO:0048661 | 1.68% | positive regulation of smooth muscle cell proliferation |
| GO:0045923 | 1.68% | positive regulation of fatty acid metabolic process |
| GO:0032535 | 1.68% | regulation of cellular component size |
| GO:0048562 | 1.68% | embryonic organ morphogenesis |
| GO:0007601 | 1.68% | visual perception |
| GO:0014059 | 1.68% | regulation of dopamine secretion |
| GO:1903573 | 1.68% | negative regulation of response to endoplasmic reticulum stress |
| GO:0009101 | 1.67% | glycoprotein biosynthetic process |
| GO:0051651 | 1.67% | maintenance of location in cell |
| GO:1902042 | 1.67% | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors |
| GO:0072593 | 1.67% | reactive oxygen species metabolic process |
| GO:0001837 | 1.67% | epithelial to mesenchymal transition |
| GO:0006611 | 1.67% | protein export from nucleus |
| GO:0051017 | 1.66% | actin filament bundle assembly |
| GO:0097485 | 1.66% | neuron projection guidance |
| GO:0008406 | 1.66% | gonad development |
| GO:0043001 | 1.66% | Golgi to plasma membrane protein transport |
| GO:0071870 | 1.66% | cellular response to catecholamine stimulus |
| GO:0045943 | 1.65% | positive regulation of transcription by RNA polymerase I |
| GO:0071773 | 1.65% | cellular response to BMP stimulus |
| GO:0032885 | 1.65% | regulation of polysaccharide biosynthetic process |
| GO:0050671 | 1.65% | positive regulation of lymphocyte proliferation |
| GO:0047484 | 1.65% | regulation of response to osmotic stress |
| GO:0021915 | 1.65% | neural tube development |
| GO:0030258 | 1.65% | lipid modification |
| GO:0001539 | 1.65% | cilium or flagellum-dependent cell motility |
| GO:1903524 | 1.65% | positive regulation of blood circulation |
| GO:0046326 | 1.65% | positive regulation of glucose import |
| GO:1901565 | 1.65% | organonitrogen compound catabolic process |
| GO:0030587 | 1.64% | sorocarp development |
| GO:0051589 | 1.64% | negative regulation of neurotransmitter transport |
| GO:0042398 | 1.64% | cellular modified amino acid biosynthetic process |
| GO:0040019 | 1.64% | positive regulation of embryonic development |
| GO:0006897 | 1.64% | endocytosis |
| GO:0032642 | 1.64% | regulation of chemokine production |
| GO:0031122 | 1.64% | cytoplasmic microtubule organization |
| GO:1903427 | 1.64% | negative regulation of reactive oxygen species biosynthetic process |
| GO:0009566 | 1.64% | fertilization |
| GO:0061844 | 1.64% | antimicrobial humoral immune response mediated by antimicrobial peptide |
| GO:0046324 | 1.64% | regulation of glucose import |
| GO:1901678 | 1.64% | iron coordination entity transport |
| GO:1901861 | 1.64% | regulation of muscle tissue development |
| GO:0042692 | 1.64% | muscle cell differentiation |
| GO:0050885 | 1.64% | neuromuscular process controlling balance |
| GO:1903649 | 1.63% | regulation of cytoplasmic transport |
| GO:0040014 | 1.63% | regulation of multicellular organism growth |
| GO:0045744 | 1.63% | negative regulation of G protein-coupled receptor signaling pathway |
| GO:0032651 | 1.63% | regulation of interleukin-1 beta production |
| GO:0030307 | 1.63% | positive regulation of cell growth |
| GO:1905521 | 1.63% | regulation of macrophage migration |
| GO:0051648 | 1.63% | vesicle localization |
| GO:0043552 | 1.63% | positive regulation of phosphatidylinositol 3-kinase activity |
| GO:0033574 | 1.63% | response to testosterone |
| GO:0051570 | 1.63% | regulation of histone H3-K9 methylation |
| GO:0051817 | 1.62% | modification of morphology or physiology of other organism involved in symbiotic interaction |
| GO:0045684 | 1.62% | positive regulation of epidermis development |
| GO:0031032 | 1.62% | actomyosin structure organization |
| GO:0030148 | 1.62% | sphingolipid biosynthetic process |
| GO:0048662 | 1.62% | negative regulation of smooth muscle cell proliferation |
| GO:0010866 | 1.62% | regulation of triglyceride biosynthetic process |
| GO:0010822 | 1.62% | positive regulation of mitochondrion organization |
| GO:0045776 | 1.61% | negative regulation of blood pressure |
| GO:1901739 | 1.61% | regulation of myoblast fusion |
| GO:0019098 | 1.61% | reproductive behavior |
| GO:0008064 | 1.61% | regulation of actin polymerization or depolymerization |
| GO:0050795 | 1.61% | regulation of behavior |
| GO:0048641 | 1.61% | regulation of skeletal muscle tissue development |
| GO:0051403 | 1.61% | stress-activated MAPK cascade |
| GO:0048636 | 1.61% | positive regulation of muscle organ development |
| GO:0002052 | 1.61% | positive regulation of neuroblast proliferation |
| GO:0030199 | 1.61% | collagen fibril organization |
| GO:0009593 | 1.61% | detection of chemical stimulus |
| GO:1903901 | 1.61% | negative regulation of viral life cycle |
| GO:0050918 | 1.61% | positive chemotaxis |
| GO:0060968 | 1.60% | regulation of gene silencing |
| GO:0010827 | 1.60% | regulation of glucose transmembrane transport |
| GO:0017085 | 1.60% | response to insecticide |
| GO:0045686 | 1.60% | negative regulation of glial cell differentiation |
| GO:1902895 | 1.60% | positive regulation of pri-miRNA transcription by RNA polymerase II |
| GO:0048666 | 1.60% | neuron development |
| GO:0001959 | 1.60% | regulation of cytokine-mediated signaling pathway |
| GO:0007411 | 1.60% | axon guidance |
| GO:0044062 | 1.59% | regulation of excretion |
| GO:1902930 | 1.59% | regulation of alcohol biosynthetic process |
| GO:0002675 | 1.59% | positive regulation of acute inflammatory response |
| GO:0043302 | 1.59% | positive regulation of leukocyte degranulation |
| GO:0051954 | 1.59% | positive regulation of amine transport |
| GO:0030216 | 1.59% | keratinocyte differentiation |
| GO:0010043 | 1.59% | response to zinc ion |
| GO:0006892 | 1.59% | post-Golgi vesicle-mediated transport |
| GO:0030855 | 1.59% | epithelial cell differentiation |
| GO:0048709 | 1.59% | oligodendrocyte differentiation |
| GO:0003382 | 1.58% | epithelial cell morphogenesis |
| GO:1903845 | 1.58% | negative regulation of cellular response to transforming growth factor beta stimulus |
| GO:0030218 | 1.58% | erythrocyte differentiation |
| GO:0002253 | 1.58% | activation of immune response |
| GO:0050953 | 1.58% | sensory perception of light stimulus |
| GO:0015918 | 1.58% | sterol transport |
| GO:0097352 | 1.57% | autophagosome maturation |
| GO:0044364 | 1.57% | disruption of cells of other organism |
| GO:0072347 | 1.57% | response to anesthetic |
| GO:0001578 | 1.57% | microtubule bundle formation |
| GO:0030512 | 1.57% | negative regulation of transforming growth factor beta receptor signaling pathway |
| GO:0036119 | 1.57% | response to platelet-derived growth factor |
| GO:1901362 | 1.57% | organic cyclic compound biosynthetic process |
| GO:0034605 | 1.57% | cellular response to heat |
| GO:0048705 | 1.57% | skeletal system morphogenesis |
| GO:0017015 | 1.56% | regulation of transforming growth factor beta receptor signaling pathway |
| GO:0043652 | 1.56% | engulfment of apoptotic cell |
| GO:1904262 | 1.56% | negative regulation of TORC1 signaling |
| GO:0007076 | 1.56% | mitotic chromosome condensation |
| GO:0007281 | 1.56% | germ cell development |
| GO:0033006 | 1.56% | regulation of mast cell activation involved in immune response |
| GO:0060964 | 1.56% | regulation of gene silencing by miRNA |
| GO:0008360 | 1.56% | regulation of cell shape |
| GO:0022029 | 1.56% | telencephalon cell migration |
| GO:0061572 | 1.55% | actin filament bundle organization |
| GO:0010718 | 1.55% | positive regulation of epithelial to mesenchymal transition |
| GO:0014014 | 1.55% | negative regulation of gliogenesis |
| GO:0014812 | 1.55% | muscle cell migration |
| GO:0046638 | 1.55% | positive regulation of alpha-beta T cell differentiation |
| GO:0007399 | 1.55% | nervous system development |
| GO:0050931 | 1.55% | pigment cell differentiation |
| GO:0045332 | 1.54% | phospholipid translocation |
| GO:0001889 | 1.54% | liver development |
| GO:0010770 | 1.54% | positive regulation of cell morphogenesis involved in differentiation |
| GO:0045667 | 1.54% | regulation of osteoblast differentiation |
| GO:0090702 | 1.54% | non-reproductive fruiting body development |
| GO:0032259 | 1.54% | methylation |
| GO:1990090 | 1.54% | cellular response to nerve growth factor stimulus |
| GO:0001895 | 1.53% | retina homeostasis |
| GO:0021533 | 1.53% | cell differentiation in hindbrain |
| GO:0036120 | 1.53% | cellular response to platelet-derived growth factor stimulus |
| GO:0051443 | 1.53% | positive regulation of ubiquitin-protein transferase activity |
| GO:0071548 | 1.53% | response to dexamethasone |
| GO:0014910 | 1.53% | regulation of smooth muscle cell migration |
| GO:0030278 | 1.53% | regulation of ossification |
| GO:0051168 | 1.53% | nuclear export |
| GO:0045723 | 1.52% | positive regulation of fatty acid biosynthetic process |
| GO:0071868 | 1.52% | cellular response to monoamine stimulus |
| GO:0045616 | 1.52% | regulation of keratinocyte differentiation |
| GO:0043030 | 1.52% | regulation of macrophage activation |
| GO:0035924 | 1.52% | cellular response to vascular endothelial growth factor stimulus |
| GO:0007626 | 1.52% | locomotory behavior |
| GO:0008380 | 1.52% | RNA splicing |
| GO:0046620 | 1.51% | regulation of organ growth |
| GO:0051148 | 1.51% | negative regulation of muscle cell differentiation |
| GO:1905710 | 1.51% | positive regulation of membrane permeability |
| GO:0007127 | 1.51% | meiosis I |
| GO:0008306 | 1.51% | associative learning |
| GO:1905562 | 1.50% | regulation of vascular endothelial cell proliferation |
| GO:1900745 | 1.50% | positive regulation of p38MAPK cascade |
| GO:0043562 | 1.50% | cellular response to nitrogen levels |
| GO:0001541 | 1.50% | ovarian follicle development |
| GO:2001239 | 1.50% | regulation of extrinsic apoptotic signaling pathway in absence of ligand |
| GO:0006066 | 1.50% | alcohol metabolic process |
| GO:0009583 | 1.50% | detection of light stimulus |
| GO:1901018 | 1.50% | positive regulation of potassium ion transmembrane transporter activity |
| GO:1903051 | 1.50% | negative regulation of proteolysis involved in cellular protein catabolic process |
| GO:0022617 | 1.49% | extracellular matrix disassembly |
| GO:0043124 | 1.49% | negative regulation of I-kappaB kinase/NF-kappaB signaling |
| GO:0097581 | 1.49% | lamellipodium organization |
| GO:0022900 | 1.49% | electron transport chain |
| GO:0010575 | 1.48% | positive regulation of vascular endothelial growth factor production |
| GO:0071549 | 1.48% | cellular response to dexamethasone stimulus |
| GO:1905953 | 1.48% | negative regulation of lipid localization |
| GO:0007224 | 1.48% | smoothened signaling pathway |
| GO:0032722 | 1.48% | positive regulation of chemokine production |
| GO:0009059 | 1.47% | macromolecule biosynthetic process |
| GO:0060674 | 1.47% | placenta blood vessel development |
| GO:0042551 | 1.47% | neuron maturation |
| GO:0045665 | 1.47% | negative regulation of neuron differentiation |
| GO:0001667 | 1.47% | ameboidal-type cell migration |
| GO:0007519 | 1.47% | skeletal muscle tissue development |
| GO:0006639 | 1.47% | acylglycerol metabolic process |
| GO:0001914 | 1.47% | regulation of T cell mediated cytotoxicity |
| GO:0050000 | 1.47% | chromosome localization |
| GO:0031532 | 1.47% | actin cytoskeleton reorganization |
| GO:0060147 | 1.47% | regulation of posttranscriptional gene silencing |
| GO:0072163 | 1.46% | mesonephric epithelium development |
| GO:0032986 | 1.46% | protein-DNA complex disassembly |
| GO:0032735 | 1.46% | positive regulation of interleukin-12 production |
| GO:0034204 | 1.46% | lipid translocation |
| GO:0060325 | 1.46% | face morphogenesis |
| GO:0048710 | 1.46% | regulation of astrocyte differentiation |
| GO:0015696 | 1.46% | ammonium transport |
| GO:0043090 | 1.46% | amino acid import |
| GO:0003002 | 1.46% | regionalization |
| GO:0040029 | 1.46% | regulation of gene expression, epigenetic |
| GO:0006082 | 1.45% | organic acid metabolic process |
| GO:0061337 | 1.45% | cardiac conduction |
| GO:0008589 | 1.45% | regulation of smoothened signaling pathway |
| GO:0032963 | 1.45% | collagen metabolic process |
| GO:0030514 | 1.45% | negative regulation of BMP signaling pathway |
| GO:0046631 | 1.45% | alpha-beta T cell activation |
| GO:0018345 | 1.45% | protein palmitoylation |
| GO:0098751 | 1.45% | bone cell development |
| GO:0030832 | 1.45% | regulation of actin filament length |
| GO:0050832 | 1.45% | defense response to fungus |
| GO:1903428 | 1.45% | positive regulation of reactive oxygen species biosynthetic process |
| GO:0099024 | 1.45% | plasma membrane invagination |
| GO:0003333 | 1.45% | amino acid transmembrane transport |
| GO:0002820 | 1.44% | negative regulation of adaptive immune response |
| GO:0046634 | 1.44% | regulation of alpha-beta T cell activation |
| GO:0032881 | 1.44% | regulation of polysaccharide metabolic process |
| GO:0071827 | 1.44% | plasma lipoprotein particle organization |
| GO:0048008 | 1.44% | platelet-derived growth factor receptor signaling pathway |
| GO:0072164 | 1.44% | mesonephric tubule development |
| GO:1905153 | 1.44% | regulation of membrane invagination |
| GO:0021983 | 1.44% | pituitary gland development |
| GO:0017144 | 1.43% | drug metabolic process |
| GO:0009948 | 1.43% | anterior/posterior axis specification |
| GO:0045879 | 1.43% | negative regulation of smoothened signaling pathway |
| GO:0071559 | 1.43% | response to transforming growth factor beta |
| GO:0001956 | 1.43% | positive regulation of neurotransmitter secretion |
| GO:0060429 | 1.42% | epithelium development |
| GO:0050770 | 1.42% | regulation of axonogenesis |
| GO:0061245 | 1.42% | establishment or maintenance of bipolar cell polarity |
| GO:0032755 | 1.42% | positive regulation of interleukin-6 production |
| GO:0044088 | 1.42% | regulation of vacuole organization |
| GO:0010324 | 1.42% | membrane invagination |
| GO:0008593 | 1.41% | regulation of Notch signaling pathway |
| GO:0010574 | 1.41% | regulation of vascular endothelial growth factor production |
| GO:0007218 | 1.41% | neuropeptide signaling pathway |
| GO:0048588 | 1.41% | developmental cell growth |
| GO:0009952 | 1.41% | anterior/posterior pattern specification |
| GO:0045472 | 1.41% | response to ether |
| GO:0007088 | 1.41% | regulation of mitotic nuclear division |
| GO:0010389 | 1.41% | regulation of G2/M transition of mitotic cell cycle |
| GO:0032768 | 1.41% | regulation of monooxygenase activity |
| GO:0035088 | 1.40% | establishment or maintenance of apical/basal cell polarity |
| GO:0098581 | 1.40% | detection of external biotic stimulus |
| GO:0030838 | 1.40% | positive regulation of actin filament polymerization |
| GO:0002221 | 1.40% | pattern recognition receptor signaling pathway |
| GO:0043304 | 1.40% | regulation of mast cell degranulation |
| GO:1903055 | 1.40% | positive regulation of extracellular matrix organization |
| GO:0031111 | 1.40% | negative regulation of microtubule polymerization or depolymerization |
| GO:0060021 | 1.40% | roof of mouth development |
| GO:0007417 | 1.39% | central nervous system development |
| GO:0002701 | 1.39% | negative regulation of production of molecular mediator of immune response |
| GO:0001937 | 1.39% | negative regulation of endothelial cell proliferation |
| GO:0046854 | 1.39% | phosphatidylinositol phosphorylation |
| GO:0006986 | 1.39% | response to unfolded protein |
| GO:0045992 | 1.39% | negative regulation of embryonic development |
| GO:0140115 | 1.39% | export across plasma membrane |
| GO:0008209 | 1.39% | androgen metabolic process |
| GO:0050851 | 1.39% | antigen receptor-mediated signaling pathway |
| GO:0006995 | 1.38% | cellular response to nitrogen starvation |
| GO:0033189 | 1.38% | response to vitamin A |
| GO:0032479 | 1.38% | regulation of type I interferon production |
| GO:0051289 | 1.38% | protein homotetramerization |
| GO:0007631 | 1.38% | feeding behavior |
| GO:0071514 | 1.37% | genetic imprinting |
| GO:0051482 | 1.37% | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway |
| GO:0008037 | 1.37% | cell recognition |
| GO:0060251 | 1.37% | regulation of glial cell proliferation |
| GO:0098815 | 1.37% | modulation of excitatory postsynaptic potential |
| GO:0019748 | 1.37% | secondary metabolic process |
| GO:0048863 | 1.37% | stem cell differentiation |
| GO:0072175 | 1.37% | epithelial tube formation |
| GO:0007617 | 1.37% | mating behavior |
| GO:0106070 | 1.36% | regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway |
| GO:0001906 | 1.36% | cell killing |
| GO:0072522 | 1.36% | purine-containing compound biosynthetic process |
| GO:0007369 | 1.36% | gastrulation |
| GO:0061436 | 1.36% | establishment of skin barrier |
| GO:0043470 | 1.36% | regulation of carbohydrate catabolic process |
| GO:0045671 | 1.36% | negative regulation of osteoclast differentiation |
| GO:0002573 | 1.36% | myeloid leukocyte differentiation |
| GO:0050853 | 1.36% | B cell receptor signaling pathway |
| GO:0030324 | 1.36% | lung development |
| GO:0045807 | 1.36% | positive regulation of endocytosis |
| GO:0060999 | 1.36% | positive regulation of dendritic spine development |
| GO:0031529 | 1.35% | ruffle organization |
| GO:0014850 | 1.35% | response to muscle activity |
| GO:0009595 | 1.35% | detection of biotic stimulus |
| GO:0035809 | 1.35% | regulation of urine volume |
| GO:1902253 | 1.35% | regulation of intrinsic apoptotic signaling pathway by p53 class mediator |
| GO:0002082 | 1.35% | regulation of oxidative phosphorylation |
| GO:0014072 | 1.35% | response to isoquinoline alkaloid |
| GO:1904707 | 1.35% | positive regulation of vascular smooth muscle cell proliferation |
| GO:0032729 | 1.35% | positive regulation of interferon-gamma production |
| GO:1903725 | 1.35% | regulation of phospholipid metabolic process |
| GO:0034391 | 1.35% | regulation of smooth muscle cell apoptotic process |
| GO:0035813 | 1.35% | regulation of renal sodium excretion |
| GO:0043436 | 1.35% | oxoacid metabolic process |
| GO:2000193 | 1.34% | positive regulation of fatty acid transport |
| GO:0031645 | 1.34% | negative regulation of nervous system process |
| GO:0019229 | 1.34% | regulation of vasoconstriction |
| GO:0071071 | 1.34% | regulation of phospholipid biosynthetic process |
| GO:0030279 | 1.34% | negative regulation of ossification |
| GO:0006911 | 1.34% | phagocytosis, engulfment |
| GO:1901623 | 1.34% | regulation of lymphocyte chemotaxis |
| GO:0006575 | 1.34% | cellular modified amino acid metabolic process |
| GO:0019438 | 1.34% | aromatic compound biosynthetic process |
| GO:0001838 | 1.34% | embryonic epithelial tube formation |
| GO:0086009 | 1.33% | membrane repolarization |
| GO:0033280 | 1.33% | response to vitamin D |
| GO:0033032 | 1.33% | regulation of myeloid cell apoptotic process |
| GO:1902230 | 1.33% | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage |
| GO:0045778 | 1.33% | positive regulation of ossification |
| GO:0060485 | 1.33% | mesenchyme development |
| GO:0030865 | 1.33% | cortical cytoskeleton organization |
| GO:0052192 | 1.33% | movement in environment of other organism involved in symbiotic interaction |
| GO:0050805 | 1.33% | negative regulation of synaptic transmission |
| GO:1903578 | 1.33% | regulation of ATP metabolic process |
| GO:1903844 | 1.32% | regulation of cellular response to transforming growth factor beta stimulus |
| GO:0006486 | 1.32% | protein glycosylation |
| GO:0009649 | 1.32% | entrainment of circadian clock |
| GO:2000648 | 1.32% | positive regulation of stem cell proliferation |
| GO:0034260 | 1.31% | negative regulation of GTPase activity |
| GO:0070085 | 1.31% | glycosylation |
| GO:0051438 | 1.31% | regulation of ubiquitin-protein transferase activity |
| GO:0003179 | 1.31% | heart valve morphogenesis |
| GO:0002823 | 1.31% | negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
| GO:0048524 | 1.31% | positive regulation of viral process |
| GO:0034219 | 1.31% | carbohydrate transmembrane transport |
| GO:0051028 | 1.31% | mRNA transport |
| GO:0046189 | 1.31% | phenol-containing compound biosynthetic process |
| GO:0035020 | 1.31% | regulation of Rac protein signal transduction |
| GO:2000406 | 1.31% | positive regulation of T cell migration |
| GO:2000278 | 1.30% | regulation of DNA biosynthetic process |
| GO:0090150 | 1.30% | establishment of protein localization to membrane |
| GO:0006479 | 1.30% | protein methylation |
| GO:0008213 | 1.30% | protein alkylation |
| GO:0018198 | 1.30% | peptidyl-cysteine modification |
| GO:0031214 | 1.30% | biomineral tissue development |
| GO:0043370 | 1.30% | regulation of CD4-positive, alpha-beta T cell differentiation |
| GO:0006338 | 1.30% | chromatin remodeling |
| GO:0006458 | 1.30% | 'de novo' protein folding |
| GO:0030032 | 1.30% | lamellipodium assembly |
| GO:0048247 | 1.30% | lymphocyte chemotaxis |
| GO:0007035 | 1.30% | vacuolar acidification |
| GO:0110148 | 1.29% | biomineralization |
| GO:0002762 | 1.29% | negative regulation of myeloid leukocyte differentiation |
| GO:1990089 | 1.29% | response to nerve growth factor |
| GO:0043537 | 1.29% | negative regulation of blood vessel endothelial cell migration |
| GO:0009950 | 1.29% | dorsal/ventral axis specification |
| GO:0009651 | 1.29% | response to salt stress |
| GO:1905037 | 1.28% | autophagosome organization |
| GO:0009409 | 1.28% | response to cold |
| GO:0048762 | 1.28% | mesenchymal cell differentiation |
| GO:0046434 | 1.28% | organophosphate catabolic process |
| GO:0046320 | 1.28% | regulation of fatty acid oxidation |
| GO:0008366 | 1.28% | axon ensheathment |
| GO:0018022 | 1.28% | peptidyl-lysine methylation |
| GO:1902914 | 1.28% | regulation of protein polyubiquitination |
| GO:0072348 | 1.28% | sulfur compound transport |
| GO:0010677 | 1.27% | negative regulation of cellular carbohydrate metabolic process |
| GO:1900426 | 1.27% | positive regulation of defense response to bacterium |
| GO:0046637 | 1.27% | regulation of alpha-beta T cell differentiation |
| GO:1903580 | 1.26% | positive regulation of ATP metabolic process |
| GO:0032506 | 1.26% | cytokinetic process |
| GO:0015893 | 1.26% | drug transport |
| GO:0044728 | 1.26% | DNA methylation or demethylation |
| GO:0031018 | 1.26% | endocrine pancreas development |
| GO:0042364 | 1.26% | water-soluble vitamin biosynthetic process |
| GO:1900424 | 1.26% | regulation of defense response to bacterium |
| GO:0035107 | 1.26% | appendage morphogenesis |
| GO:0030534 | 1.25% | adult behavior |
| GO:0015749 | 1.25% | monosaccharide transmembrane transport |
| GO:0120162 | 1.25% | positive regulation of cold-induced thermogenesis |
| GO:0010758 | 1.25% | regulation of macrophage chemotaxis |
| GO:0052126 | 1.25% | movement in host environment |
| GO:0007632 | 1.25% | visual behavior |
| GO:0070193 | 1.25% | synaptonemal complex organization |
| GO:0002690 | 1.25% | positive regulation of leukocyte chemotaxis |
| GO:0002834 | 1.25% | regulation of response to tumor cell |
| GO:0006508 | 1.25% | proteolysis |
| GO:0043567 | 1.25% | regulation of insulin-like growth factor receptor signaling pathway |
| GO:0046636 | 1.24% | negative regulation of alpha-beta T cell activation |
| GO:0048525 | 1.24% | negative regulation of viral process |
| GO:0140238 | 1.24% | presynaptic endocytosis |
| GO:0098901 | 1.24% | regulation of cardiac muscle cell action potential |
| GO:0006110 | 1.24% | regulation of glycolytic process |
| GO:0006814 | 1.24% | sodium ion transport |
| GO:0043603 | 1.24% | cellular amide metabolic process |
| GO:0035019 | 1.24% | somatic stem cell population maintenance |
| GO:1904706 | 1.24% | negative regulation of vascular smooth muscle cell proliferation |
| GO:0006638 | 1.24% | neutral lipid metabolic process |
| GO:0001659 | 1.24% | temperature homeostasis |
| GO:0060047 | 1.24% | heart contraction |
| GO:2000369 | 1.24% | regulation of clathrin-dependent endocytosis |
| GO:0070169 | 1.23% | positive regulation of biomineral tissue development |
| GO:0006282 | 1.23% | regulation of DNA repair |
| GO:0046034 | 1.23% | ATP metabolic process |
| GO:0035264 | 1.23% | multicellular organism growth |
| GO:0042832 | 1.23% | defense response to protozoan |
| GO:0061028 | 1.23% | establishment of endothelial barrier |
| GO:0019731 | 1.23% | antibacterial humoral response |
| GO:0034502 | 1.23% | protein localization to chromosome |
| GO:1901136 | 1.23% | carbohydrate derivative catabolic process |
| GO:0010596 | 1.22% | negative regulation of endothelial cell migration |
| GO:0051646 | 1.22% | mitochondrion localization |
| GO:1901863 | 1.22% | positive regulation of muscle tissue development |
| GO:0060306 | 1.22% | regulation of membrane repolarization |
| GO:0043278 | 1.22% | response to morphine |
| GO:0014032 | 1.22% | neural crest cell development |
| GO:0048858 | 1.22% | cell projection morphogenesis |
| GO:0090598 | 1.22% | male anatomical structure morphogenesis |
| GO:0060966 | 1.21% | regulation of gene silencing by RNA |
| GO:0044770 | 1.21% | cell cycle phase transition |
| GO:0001773 | 1.21% | myeloid dendritic cell activation |
| GO:0048857 | 1.21% | neural nucleus development |
| GO:0098876 | 1.21% | vesicle-mediated transport to the plasma membrane |
| GO:0042552 | 1.21% | myelination |
| GO:0044271 | 1.21% | cellular nitrogen compound biosynthetic process |
| GO:0006826 | 1.20% | iron ion transport |
| GO:2000573 | 1.20% | positive regulation of DNA biosynthetic process |
| GO:0032967 | 1.20% | positive regulation of collagen biosynthetic process |
| GO:0060415 | 1.20% | muscle tissue morphogenesis |
| GO:0048635 | 1.20% | negative regulation of muscle organ development |
| GO:0048592 | 1.20% | eye morphogenesis |
| GO:0010614 | 1.20% | negative regulation of cardiac muscle hypertrophy |
| GO:0022618 | 1.20% | ribonucleoprotein complex assembly |
| GO:0060048 | 1.19% | cardiac muscle contraction |
| GO:0032655 | 1.19% | regulation of interleukin-12 production |
| GO:0034405 | 1.19% | response to fluid shear stress |
| GO:0048738 | 1.19% | cardiac muscle tissue development |
| GO:0032732 | 1.19% | positive regulation of interleukin-1 production |
| GO:0032731 | 1.19% | positive regulation of interleukin-1 beta production |
| GO:0006605 | 1.19% | protein targeting |
| GO:0006397 | 1.19% | mRNA processing |
| GO:0050852 | 1.19% | T cell receptor signaling pathway |
| GO:1905939 | 1.18% | regulation of gonad development |
| GO:1905606 | 1.18% | regulation of presynapse assembly |
| GO:0003156 | 1.18% | regulation of animal organ formation |
| GO:0046834 | 1.18% | lipid phosphorylation |
| GO:0051783 | 1.18% | regulation of nuclear division |
| GO:0035249 | 1.18% | synaptic transmission, glutamatergic |
| GO:0048146 | 1.18% | positive regulation of fibroblast proliferation |
| GO:0032787 | 1.18% | monocarboxylic acid metabolic process |
| GO:0018023 | 1.17% | peptidyl-lysine trimethylation |
| GO:0048521 | 1.17% | negative regulation of behavior |
| GO:0042059 | 1.17% | negative regulation of epidermal growth factor receptor signaling pathway |
| GO:0042447 | 1.17% | hormone catabolic process |
| GO:0006900 | 1.17% | vesicle budding from membrane |
| GO:0030042 | 1.17% | actin filament depolymerization |
| GO:0140029 | 1.17% | exocytic process |
| GO:0002920 | 1.17% | regulation of humoral immune response |
| GO:0048640 | 1.17% | negative regulation of developmental growth |
| GO:0007272 | 1.17% | ensheathment of neurons |
| GO:0007032 | 1.16% | endosome organization |
| GO:0006730 | 1.16% | one-carbon metabolic process |
| GO:0007007 | 1.16% | inner mitochondrial membrane organization |
| GO:0080171 | 1.16% | lytic vacuole organization |
| GO:0009642 | 1.16% | response to light intensity |
| GO:0071276 | 1.16% | cellular response to cadmium ion |
| GO:0035112 | 1.16% | genitalia morphogenesis |
| GO:1901797 | 1.16% | negative regulation of signal transduction by p53 class mediator |
| GO:0030890 | 1.16% | positive regulation of B cell proliferation |
| GO:1901099 | 1.16% | negative regulation of signal transduction in absence of ligand |
| GO:0042100 | 1.16% | B cell proliferation |
| GO:0046627 | 1.16% | negative regulation of insulin receptor signaling pathway |
| GO:0061512 | 1.16% | protein localization to cilium |
| GO:0008645 | 1.16% | hexose transmembrane transport |
| GO:0030857 | 1.16% | negative regulation of epithelial cell differentiation |
| GO:0008585 | 1.16% | female gonad development |
| GO:1901615 | 1.15% | organic hydroxy compound metabolic process |
| GO:0046173 | 1.15% | polyol biosynthetic process |
| GO:0090025 | 1.15% | regulation of monocyte chemotaxis |
| GO:0061951 | 1.15% | establishment of protein localization to plasma membrane |
| GO:0008544 | 1.15% | epidermis development |
| GO:0048260 | 1.15% | positive regulation of receptor-mediated endocytosis |
| GO:0043951 | 1.15% | negative regulation of cAMP-mediated signaling |
| GO:0006275 | 1.15% | regulation of DNA replication |
| GO:0001974 | 1.15% | blood vessel remodeling |
| GO:0070417 | 1.15% | cellular response to cold |
| GO:0042461 | 1.15% | photoreceptor cell development |
| GO:0045601 | 1.15% | regulation of endothelial cell differentiation |
| GO:0032922 | 1.15% | circadian regulation of gene expression |
| GO:1901361 | 1.15% | organic cyclic compound catabolic process |
| GO:0044242 | 1.15% | cellular lipid catabolic process |
| GO:0007033 | 1.15% | vacuole organization |
| GO:0042698 | 1.15% | ovulation cycle |
| GO:0032770 | 1.15% | positive regulation of monooxygenase activity |
| GO:0097028 | 1.15% | dendritic cell differentiation |
| GO:1901796 | 1.14% | regulation of signal transduction by p53 class mediator |
| GO:0000018 | 1.14% | regulation of DNA recombination |
| GO:0060322 | 1.14% | head development |
| GO:0030574 | 1.14% | collagen catabolic process |
| GO:0006259 | 1.14% | DNA metabolic process |
| GO:0051341 | 1.14% | regulation of oxidoreductase activity |
| GO:0035188 | 1.14% | hatching |
| GO:0002224 | 1.14% | toll-like receptor signaling pathway |
| GO:0050891 | 1.14% | multicellular organismal water homeostasis |
| GO:0051353 | 1.14% | positive regulation of oxidoreductase activity |
| GO:0042982 | 1.14% | amyloid precursor protein metabolic process |
| GO:0034440 | 1.13% | lipid oxidation |
| GO:0120039 | 1.13% | plasma membrane bounded cell projection morphogenesis |
| GO:0048704 | 1.13% | embryonic skeletal system morphogenesis |
| GO:0050830 | 1.13% | defense response to Gram-positive bacterium |
| GO:0051193 | 1.13% | regulation of cofactor metabolic process |
| GO:0110151 | 1.13% | positive regulation of biomineralization |
| GO:0040018 | 1.12% | positive regulation of multicellular organism growth |
| GO:0045600 | 1.12% | positive regulation of fat cell differentiation |
| GO:0045604 | 1.12% | regulation of epidermal cell differentiation |
| GO:0016569 | 1.12% | covalent chromatin modification |
| GO:0016570 | 1.12% | histone modification |
| GO:0044458 | 1.12% | motile cilium assembly |
| GO:0016049 | 1.12% | cell growth |
| GO:1904892 | 1.11% | regulation of receptor signaling pathway via STAT |
| GO:1903311 | 1.11% | regulation of mRNA metabolic process |
| GO:0006521 | 1.11% | regulation of cellular amino acid metabolic process |
| GO:0007030 | 1.11% | Golgi organization |
| GO:0010453 | 1.11% | regulation of cell fate commitment |
| GO:0000045 | 1.11% | autophagosome assembly |
| GO:0002673 | 1.11% | regulation of acute inflammatory response |
| GO:0006884 | 1.11% | cell volume homeostasis |
| GO:1905207 | 1.11% | regulation of cardiocyte differentiation |
| GO:0071711 | 1.11% | basement membrane organization |
| GO:0051146 | 1.11% | striated muscle cell differentiation |
| GO:0051952 | 1.10% | regulation of amine transport |
| GO:0032273 | 1.10% | positive regulation of protein polymerization |
| GO:0045823 | 1.10% | positive regulation of heart contraction |
| GO:0045197 | 1.10% | establishment or maintenance of epithelial cell apical/basal polarity |
| GO:0008154 | 1.10% | actin polymerization or depolymerization |
| GO:0014896 | 1.10% | muscle hypertrophy |
| GO:0060541 | 1.10% | respiratory system development |
| GO:0008361 | 1.10% | regulation of cell size |
| GO:1903313 | 1.10% | positive regulation of mRNA metabolic process |
| GO:0060148 | 1.10% | positive regulation of posttranscriptional gene silencing |
| GO:0002062 | 1.09% | chondrocyte differentiation |
| GO:0061640 | 1.09% | cytoskeleton-dependent cytokinesis |
| GO:0090224 | 1.09% | regulation of spindle organization |
| GO:0044703 | 1.09% | multi-organism reproductive process |
| GO:0006767 | 1.09% | water-soluble vitamin metabolic process |
| GO:0045071 | 1.09% | negative regulation of viral genome replication |
| GO:0071880 | 1.09% | adenylate cyclase-activating adrenergic receptor signaling pathway |
| GO:0002828 | 1.09% | regulation of type 2 immune response |
| GO:0007163 | 1.08% | establishment or maintenance of cell polarity |
| GO:0051186 | 1.08% | cofactor metabolic process |
| GO:0007628 | 1.08% | adult walking behavior |
| GO:0034330 | 1.08% | cell junction organization |
| GO:0033627 | 1.08% | cell adhesion mediated by integrin |
| GO:0048240 | 1.08% | sperm capacitation |
| GO:0033363 | 1.08% | secretory granule organization |
| GO:0021782 | 1.08% | glial cell development |
| GO:0001835 | 1.07% | blastocyst hatching |
| GO:0060041 | 1.07% | retina development in camera-type eye |
| GO:1901673 | 1.07% | regulation of mitotic spindle assembly |
| GO:0021675 | 1.07% | nerve development |
| GO:0009635 | 1.07% | response to herbicide |
| GO:0035024 | 1.07% | negative regulation of Rho protein signal transduction |
| GO:0007051 | 1.07% | spindle organization |
| GO:0071300 | 1.07% | cellular response to retinoic acid |
| GO:0045687 | 1.06% | positive regulation of glial cell differentiation |
| GO:0014912 | 1.06% | negative regulation of smooth muscle cell migration |
| GO:0034285 | 1.06% | response to disaccharide |
| GO:0031016 | 1.06% | pancreas development |
| GO:0032728 | 1.06% | positive regulation of interferon-beta production |
| GO:0033005 | 1.06% | positive regulation of mast cell activation |
| GO:0032814 | 1.06% | regulation of natural killer cell activation |
| GO:1903902 | 1.06% | positive regulation of viral life cycle |
| GO:0016571 | 1.06% | histone methylation |
| GO:0032196 | 1.06% | transposition |
| GO:0046839 | 1.06% | phospholipid dephosphorylation |
| GO:0035710 | 1.06% | CD4-positive, alpha-beta T cell activation |
| GO:0006855 | 1.06% | drug transmembrane transport |
| GO:0048278 | 1.06% | vesicle docking |
| GO:0007040 | 1.06% | lysosome organization |
| GO:0006631 | 1.06% | fatty acid metabolic process |
| GO:0008584 | 1.05% | male gonad development |
| GO:0044380 | 1.05% | protein localization to cytoskeleton |
| GO:0001944 | 1.05% | vasculature development |
| GO:0044706 | 1.05% | multi-multicellular organism process |
| GO:0022904 | 1.05% | respiratory electron transport chain |
| GO:1900076 | 1.05% | regulation of cellular response to insulin stimulus |
| GO:0048812 | 1.05% | neuron projection morphogenesis |
| GO:0030517 | 1.04% | negative regulation of axon extension |
| GO:0000281 | 1.04% | mitotic cytokinesis |
| GO:0055024 | 1.04% | regulation of cardiac muscle tissue development |
| GO:1905039 | 1.04% | carboxylic acid transmembrane transport |
| GO:0043487 | 1.04% | regulation of RNA stability |
| GO:0002263 | 1.04% | cell activation involved in immune response |
| GO:0071826 | 1.04% | ribonucleoprotein complex subunit organization |
| GO:1904659 | 1.04% | glucose transmembrane transport |
| GO:0030317 | 1.04% | flagellated sperm motility |
| GO:1901798 | 1.04% | positive regulation of signal transduction by p53 class mediator |
| GO:0043950 | 1.04% | positive regulation of cAMP-mediated signaling |
| GO:0007062 | 1.03% | sister chromatid cohesion |
| GO:0019835 | 1.03% | cytolysis |
| GO:0002218 | 1.03% | activation of innate immune response |
| GO:2000178 | 1.03% | negative regulation of neural precursor cell proliferation |
| GO:1902115 | 1.03% | regulation of organelle assembly |
| GO:0072595 | 1.03% | maintenance of protein localization in organelle |
| GO:0051656 | 1.03% | establishment of organelle localization |
| GO:1901137 | 1.03% | carbohydrate derivative biosynthetic process |
| GO:0021549 | 1.03% | cerebellum development |
| GO:0046879 | 1.03% | hormone secretion |
| GO:0016458 | 1.02% | gene silencing |
| GO:0046697 | 1.02% | decidualization |
| GO:0002286 | 1.02% | T cell activation involved in immune response |
| GO:0046626 | 1.02% | regulation of insulin receptor signaling pathway |
| GO:0033013 | 1.02% | tetrapyrrole metabolic process |
| GO:1905508 | 1.02% | protein localization to microtubule organizing center |
| GO:0071353 | 1.01% | cellular response to interleukin-4 |
| GO:0051580 | 1.01% | regulation of neurotransmitter uptake |
| GO:0072073 | 1.01% | kidney epithelium development |
| GO:1903825 | 1.01% | organic acid transmembrane transport |
| GO:1903432 | 1.01% | regulation of TORC1 signaling |
| GO:0086091 | 1.01% | regulation of heart rate by cardiac conduction |
| GO:0048488 | 1.01% | synaptic vesicle endocytosis |
| GO:0051972 | 1.01% | regulation of telomerase activity |
| GO:1900077 | 1.01% | negative regulation of cellular response to insulin stimulus |
| GO:0097722 | 1.01% | sperm motility |
| GO:0090162 | 1.01% | establishment of epithelial cell polarity |
| GO:0017145 | 1.01% | stem cell division |
| GO:0033238 | 1.01% | regulation of cellular amine metabolic process |
| GO:0015807 | 1.01% | L-amino acid transport |
| GO:0014048 | 1.00% | regulation of glutamate secretion |
| GO:0045662 | 1.00% | negative regulation of myoblast differentiation |
| GO:0016482 | 1.00% | cytosolic transport |
| GO:0051653 | 1.00% | spindle localization |